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4 Introduction
1.1 Breast Cancer and Imaging
Breast cancer is the leading cause of cancer death in women worldwide1. Only in
Europe, on average 421 000 women are diagnosed with breast cancer and 129 000
women die from the disease each year2. Some of the most important risk factors for
developing breast cancer are known as breast density (BD), age, BRCA gene status and
family history.
Anatomy of a breast is illustrated in Fig. 1.1. Cancers that grow within milk ducts or
lobules of the breast are called in situ cancers, namely ductal carcinoma in situ (DCIS)
and lobular carcinoma in situ (LCIS). Cancers that inltrate outside of ducts and lobules
are called invasive cancers. Although there are several specic histological types dened
for invasive cancers (such as tubular, lobular, medullary, mucoid, apocrine, anaplastic,
etc.), most invasive cancers are not specically classied but fall in the group of `no
specic type' cancers and are commonly referred to as invasive ductal carcinomas (IDC).
In general in situ cancers cannot metastasize and are therefore completely cured when
resected. However in situ cancers possess the risk of becoming invasive. Treatment
options and prognosis for invasive cancers depend on whether the cancer has spread
into the lymph nodes or other organs. Therefore early detection of breast cancer has a
primal importance in reducing the mortality rates.
Breast cancers are also classied according to their histopathological grades and
molecular subtypes. Histopathological grade is dened with values 1, 2 or 3; higher
grade meaning more aggressiveness and faster growth. Molecular subtypes are related
to the genetic prole of the cancer cells. Some of the most often used molecular markers
that determine the molecular subtype are estrogen receptors (ER), progesterone recep-
tors (PR) and human epidermal growth factor receptor 2 (HER2). These subtypes may
help in identifying possible targeted therapies, such as tamoxifen for ER+ cancers or
trastuzumab for HER2+ cancers.
Since the life expectancy largely depends on the stage of the cancer when it is de-
tected, screening programs have been introduced for detecting breast cancer as early as
possible. Currently screening programs are performed with mammography. Although
benets of mammography-based screening have been shown3,4, it has serious disadvan-
tages. It has the lowest sensitivity for the women with dense breasts5, which is the
group of women with the highest risk of developing breast cancer, four to six times
higher compared to the women that have low density breasts6. Compared to mammog-
raphy, breast magnetic resonance imaging (MRI) is known to have very high sensitivity
levels, as high as 91% according to a meta-analysis7, which increases further with the
recent advances, especially with the introduction of 3T MRI scanners8. Moreover, it
has been shown that mammography has a low sensitivity for high-grade DCIS lesions,
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Figure 1.1: Illustration of the tissues in breast and in its surrounding. Most of the breast cancers
develop in milk ducts or lobules. (Image from http://nbcf.org.au).
while MRI has a high sensitivity for such lesions9. Therefore, breast MRI is superior
to mammography in detecting breast cancer. However, its high cost and the necessity
of the use of a contrast agent limits wide use of breast MRI. Currently, screening with
breast MRI is performed only for the women with increased breast cancer risk. In the
recent years there have been several studies on novel abbreviated breast MRI proto-
cols and ultrafast dynamic contrast-enhanced MRI (DCE-MRI) sequences to reduce the
cost, which may help in application of breast MRI for general screening.
1.2 Breast MRI
The main component of a breast magnetic resonance imaging (MRI) protocol is the
dynamic contrast enhanced MRI (DCE-MRI) series, which is typically based on ac-
quisition of T1-weighted (T1w) volumes and administration of a contrast agent. The
most commonly used contrast agents for DCE-MRI are Gadolinium (Gd) based, which
shortens T1 relaxation time of the tissue that uptakes this contrast agent. This makes
the tissue appear brighter in the T1w MRI volumes. Although malignant lesions share
the same T1w properties with healthy breast parenchyma (also referred to as brog-
landular tissue - FGT), making them indistinguishable in T1w volumes, uptake of the
contrast agent by these lesions make them distinguishable.
6 Introduction
Figure 1.2: Angiogenesis process. (Image from www.lungevity.org).
1.2.1 Pathophysiological Basis of Contrast Enhancement
The physiology behind contrast uptake by the cancer tissue is related to angiogenesis, a
physiological process of formation of new vessels. Since cancer cells proliferate rapidly,
they need a large amount of metabolites and oxygen. In the initial phase, when the
tumor is small, these nutrients can be supplied through diusion. As the tumor grows,
the need for nutrients increases, and, at this stage, cancer cells start secreting vascular
endothelial growth factor (VEGF) protein, which stimulates the formation of blood
cells. By this angiogenesis process, tumors become able to obtain nutrients directly
from blood vessels (Fig. 1.2).
The vessel structures produced by the angiogenesis processes in cancer are dier-
ent from those in normal tissue. They have increased microvessel density with many
distorted and twisting capillaries that have immature walls10. The increased vascu-
larity and highly permeable capillary walls in cancer tissue results in a rapid uptake
of contrast agent in high amounts. The same leaky character of these capillaries also
causes a rapid washout of the contrast agent after its uptake. As a result, the type of
vascularity formed by angiogenesis in cancer tumors not only allows enhancement of
these tumors, but also gives the enhancement a specic dynamic character that helps
in dierentiating them from other enhancing structures. Vascularity around a lesion
may be visible in MRI as given in the example in Fig 1.3.
1.2.2 DCE-MRI of the Breast: Conventional and Novel Protocols
Most DCE-MRI protocols consist of several T1w volume acquisitions. Initially, a T1w
volume is obtained before contrast agent has been administrated. We refer to this
volume as the `pre-contrast' volume. Then, to make the lesions visible, the contrast
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Figure 1.3: An example of a lesion imaged with MRI, where vessels connected to the lesions are visible.
agent is injected to the patient, which is followed by a second T1w volume acquisition,
referred to as the `post-contrast' volume. Lesions appear clearly in the subtraction
volume obtained from pre- and post-contrast volumes. However, not only malignant
lesions, but also some of the benign lesions, such as broadenomas, enhance in breast
DCE-MRI. Characterization of lesions into benign or malignant is performed using
morphological and dynamic information.
Dynamic properties of lesions in DCE-MRI refer to how contrast enhancement of
a tissue changes over time during an imaging session, after the contrast agent is ad-
ministered. Because of the leakiness of the tumor vessels created by the angiogenesis
process, most malignant lesions enhance rapidly, followed by a decrease in enhance-
ment that corresponds to the washout of the contrast agent from the tissue. In princi-
ple, contrast enhancement dynamics of tissues can be monitored by obtaining multiple
post-contrast T1w volumes. However, obtaining this dynamic information in a high
temporal resolution conicts with the demand for high spatial resolution that is needed
for morphological analysis of the lesions. Therefore, in conventional DCE-MRI pro-
tocols, high spatial and low temporal resolution is preferred. Because of the limited
temporal resolution, it is not easy to monitor the rapid contrast uptake of the lesions.
Hence, dynamic evaluation of the lesions is based on the late-phase of the contrast
enhancement, where a gradual washout, i.e., decrease in the intensity of the malignant
lesions, can be observed in repeated T1w acquisitions. The common practice is to clas-
sify signal intensity curves in the late phase into 3 types: type 1 (persistent), type 2
(plateau) and type 3 (washout) as given in Fig. 1.4, where a washout shape is consid-
ered as a strong indication of malignancy. In a study by Kuhl et al., the percentages of
malignant lesions with type 1, 2 and 3 curves were 8.9%, 33.6% and 57.4%, respectively,
in a series of 266 breast lesions11.
The conict between spatial and temporal resolution has been tackled in novel ul-
trafast DCE-MRI sequences that use view-sharing techniques, by which high resolution
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Figure 1.4: Curve types. (Image from www.mriquestions.com).
in both temporal and spatial domains can be achieved12{14. View-sharing technique is
based on sharing k-space information between subsequent acquisitions in a DCE-MRI
protocol. A smaller central region of k-space that denes low-frequency information
of an image is sampled at each scan, while the outer region of the k-space is sampled
partially and the rest of the points in the k-space are copied from previous scans, which
allow rapid acquisitions. In this way, a high temporal resolution can be obtained with-
out compromising much from the spatial resolution. High temporal resolution is useful
to capture contrast uptake behavior of the tissue in the early phase. Because of the
angiogenetic properties of malignant lesions, they enhance faster than benign lesions.
It has been shown that, using early phase contrast-uptake information obtained from
ultrafast sequences leads to a higher diagnostic accuracy compared to the conventional
evaluation of the washout in the late-phase15. Therefore these novel ultrafast DCE-MRI
sequences hold a great potential for the future of breast MRI.
In clinical acquisition protocols, the dynamic and morphological information pro-
vided by the DCE-MRI series is enriched by additional acquisitions such as diusion-
weighted imaging (DWI) and T2-weighted imaging (T2w). High cellularity in malignant
lesions limit diusion of water molecules that makes them appear darker than healthy
parenchymal tissue in apparent diusion coecient (ADC) maps obtained from DWI16.
T2w imaging has been found to be useful especially in younger women to conrm the
diagnosis of benignity established by the dynamic or morphological analysis17. As a re-
sult, the adjunct MRI volumes obtained from DWI and T2w imaging help in increasing
specicity of the breast MRI further.
1.3 Automated Analysis of Breast MRI
The imaging information obtained in a breast MRI study has a high dimensional and
multiparametric nature, which makes reading of these images a dicult and time con-
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suming task. To increase reading eciency and accuracy of the radiologists, several
automated tools, based on computer vision and machine learning techniques, are being
developed. These applications include segmentation and quantication of breast and
parenchymal tissue, automated lesion detection and classication. Although we call
these methods `automated', none of the current methods have reached a performance
level that allows them to be used as a standalone automated tool. Therefore, currently,
such systems can only be used to aid radiologists by increasing their reading eciency.
Future research is needed to improve them. Another limitation of the current meth-
ods18{28 is that they are based on conventional breast MRI protocols, while there is a
continuous progress in this eld and novel protocols are being developed and applied
in clinical practice. One example is the abbreviated breast MRI protocols that are sug-
gested for screening29,30, in which late phase acquisitions are not obtained and lesions
are interpreted only based on morphological properties. In such protocols, it is criti-
cal to exploit all shape information available in a single subtraction volume, whereas
previously developed algorithms substantially rely on temporal contrast enhancement
dynamics. Another example is the ultrafast DCE-MRI sequences12{14, where type of
dynamic information is completely dierent than that obtained from the conventional
DCE-MRI sequences. Considering that both of these novel protocols can be key in
wider use of breast MRI (i.e. screening), it becomes even more important to have auto-
mated methods for ecient reading of these exams, since long reading times of breast
MRI is another diculty that limits wide use of it.
1.3.1 Transition to Deep Learning
Since 2012, we have been witnessing rapid and revolutionary changes in the elds of
machine learning, computer vision, and, consequently, medical image analysis with
the advent of the algorithms named as `deep learning'. These elds changed literally
overnight when the 2012 ILSVRC ImageNet challenge was won by a large margin using
the method described by Alex Krizhevsky, Ilya Sutskever and Georey Hinton in their
paper `ImageNet Classication with Deep Convolutional Networks'31. The error rate
they obtained with this method was 16.4%, while the top performing algorithms of the
previous years had error rates of 25.8% and 28.2%. Deep learning methods have been
improved further with explosively increasing number of studies since from 2012, being
the method of choice in automated image analysis.
There are two main aspects of deep learning methods, the rst one being automated
feature learning. In traditional machine learning and computer vision approaches, fea-
tures are engineered specially for each problem, which are then used in a classication
or a regression algorithm. In contrast, there is no such feature design in deep learning
methods, since features are automatically learned from examples. The other important
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Figure 1.5: \LeNet" CNN published by LeCun et al.32.
aspect of deep learning methods is depth, which refers to the use of several layers of
representations needed for recognition of the objects. Each representation layer in deep
learning is a simple but non-linear module, which can generate very complex functions
when combined33. Most commonly, these representation layers are implemented by
convolution operations using `convolutional neural networks' (CNN). Although this ap-
proach is not completely new, one of the earlier successful applications being `LeNet'
CNN (Fig. 1.5) from 199832, use of deeper CNNs has been made possible by the in-
troduction of powerful graphical processors that can handle parallel processing of large
amount of matrix operations, availability of large datasets for training and various
new tricks that improve the training process. As illustrated in Fig. 1.5, a gure that
has been classic to describe CNNs, these networks consist of subsequent convolutional
and subsampling layers followed by a stack of fully connected layers (FCN), which is
basically an articial neural network classier. For each convolutional layer, a non-
linearity operation is added to allow generation of complex non-linear representations
in combination of these layers. The last component of a CNN classier is commonly
implemented using a softmax function that generates likelihood values for each class.
During training, the error between the actual label and the softmax output is back-
propagated to the network, a process through which weight values in the network are
updated.
The medical image analysis community has also adopted these methods later but in
an increasing pace. In a survey on deep learning in medical image analysis, Litjens et
al. reviewed 308 articles published from 2014 until early 2017 that use deep learning
for analyzing medical images from several dierent domains. Two hundred and forty
two (242) of these papers were published in the last year of this period34. It was seen
that, in all medical imaging domains that were reviewed in this survey, deep learning
algorithms outperformed the previous conventional methods. As a result, deep learning
has become the main method of choice in medical image analysis.
1.4 Thesis Outline 11
1.4 Thesis Outline
This thesis describes several methods to automatically analyze breast MRI acquired us-
ing novel protocols, reecting the shift from conventional approaches into deep learning
techniques in the eld of medical image analysis. Chapter 2 describes an automated
classication method for breast lesions imaged with a novel ultrafast DCE-MRI proto-
col. Conventional feature extraction and classication methods were used in this study.
Starting from the second chapter we investigated the use of deep learning methods for
automated analysis of breast MRI. In chapter 3, we present an automated segmenta-
tion method for breast MRI using fully convolutional deep neural networks. This work
includes segmentation of breast and broglandular tissue (parenchyma) and subsequent
estimation of BD based on these segmentations. In chapter 4, we applied the developed
segmentation method on a large MRI dataset for a retrospective analysis of breast can-
cer risk and various automatically computed measures such as background parenchymal
enhancement (BPE), BD and FGT amount in a population of women with increased
breast cancer risk. Chapter 5 focuses on exploiting the spatial information available in
subtraction volumes in breast MRI using deep learning techniques for automated lesion
detection in abbreviated protocols. In chapter 6, we revisited the problem of classi-
cation of lesions imaged with novel ultrafast DCE-MRI protocols, but this time with
deep learning. We also investigated the use of adjunct imaging that is used in clinical
protocols to increase specicity. The last chapter includes a summary and a discussion
about future directions in breast MRI and its automated analysis.
A computer-aided diagnosis system for ultra-
fast breast DCE-MRI
2
Mehmet Ufuk Dalmıs¸, Albert Gubern-Mérida, Suzan Vreemann, Nico Karssemeijer,
Ritse Mann, Bram Platel
Original title: A computer-aided diagnosis system for breast DCE-MRI at high
spatiotemporal resolution.
Published in: Medical Physics (2016); 43(1): 84-94
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Abstract
Purpose: With novel MRI sequences, high spatiotemporal resolution has become avail-
able in DCE-MRI of the breast. Since benign structures in the breast can show enhance-
ment similar to malignancies in DCE-MRI, characterization of detected lesions is an
important problem. The purpose of this study is to develop a computer-aided diagnosis
(CADx) system for characterization of breast lesions imaged with high spatiotemporal
resolution DCE-MRI.
Methods: The developed CADx system is composed of four main parts: semi-
automated lesion segmentation, automated computation of morphological and dynamic
features, aorta detection and classication between benign and malignant categories.
Lesion segmentation is performed by using a `multi-seed smart opening' algorithm. Five
morphological features were computed based on the segmentation of the lesion. For each
voxel, contrast enhancement curve was tted to an exponential model and dynamic
features were computed based on this tted curve. Average and standard deviation of
the dynamic features were computed over the entire segmented area, in addition to the
average value in an automatically selected smaller `most suspicious region'. To compute
the dynamic features for an enhancement curve, information of aortic enhancement is
also needed. To keep the system fully automated, we developed a component which
automatically detects the aorta and computes the aortic enhancement time. We used
random forests algorithm to classify benign lesions from malignant. We evaluated
this system in a dataset of breast MRI scans of 325 patients with 223 malignant and
172 benign lesions, and compared its performance to an existing approach. We also
evaluated the classication performances for DCIS, IDC and ILC lesions separately.
The classication performances were measured by ROC analysis in a leave-one-out
cross validation scheme.
Results: The area under the ROC curve (AUC) obtained by the proposed CADx
system was 0.8543, which was signicantly higher (p=0.007) than the performance
obtained by the previous CADx system (0.8172) on the same dataset. The AUC values
for DCIS, IDC and ILC lesions were 0.7924, 0.8688 and 0.8650, respectively.
Conclusions: We developed a CADx system for high spatiotemporal resolution DCE-
MRI of the breast. This system outperforms a previously proposed system in classifying
benign and malignant lesions, while it requires less user interactions.
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2.1 Introduction
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has become an
indispensable part of breast care, with its high sensitivity for breast cancer and its
ability to show the extent of the disease. In meta-analysis7 sensitivity of DCE-MRI is
as high as 90% for detection of breast cancers, while newer studies have reported even
higher values using 3 Tesla MR scanners and high relaxivity contrast agents8. However,
in DCE-MRI benign structures in the breast can show enhancement similar to malig-
nancies. The characterization of detected lesions is therefore an important problem.
To separate benign enhancing structures from the malignant ones, both morphology
of the lesion and dynamics of the contrast enhancement are considered35. For an ac-
curate morphological evaluation, high spatial resolution protocols are mandatory often
at the expense of temporal resolution. For dynamic evaluation, late phase information
(washout) is considered in clinical practice, as this does not require a high temporal
imaging resolution. However, this requires additional late-phase post-contrast MRI ac-
quisitions, which increase the duration of the MRI scans and, therefore, increase the
cost15.
Novel MRI sequences allow acquisition of DCE-MR images in high temporal and
spatial (spatiotemporal) resolution. TWIST by Siemens, TRICKS XV by GE and 4D-
TRAK by Philips are examples of these sequences12{14. With high temporal resolution
sequences, it is possible to capture the early contrast uptake behavior of lesions, and
evaluate contrast enhancement during the wash-in phase, rather than during the wash-
out phase. Since spatial resolution is almost fully preserved, morphological evaluation
is still possible with these MRI protocols. A previous study15 demonstrated that the
diagnostic accuracy of evaluating a single parameter of the early uptake dynamics of
the enhancement curve (`maximum slope') with high temporal resolution is superior to
the conventional evaluation of the late phase dynamics (`curve type') of the contrast
enhancement curve.
Due to the high number of lesions (both benign and malignant) found in breast MRI,
there is a need for further improvement of lesion classication as the emotional and -
nancial burden of biopsies for benign lesions is substantial. Platel et al.36 described
a CADx system for TWIST DCE-MRI acquisitions, where several semi-quantitative
features were computed to describe the contrast uptake curve. Some of these features
were designed to measure how fast the lesion enhances, since a fast enhancement is in-
dicative of malignancy. These features were normalized by using the enhancement time
of the descending aorta as point zero to compensate for varying cardiac output and cir-
culation times within the body. This CADx system showed an acceptable performance
in separating benign from malignant lesions. However, aortic enhancement time was
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determined manually in this system. Manual determination of the aortic enhancement
time increases the reading time for radiologists and is subjective. Furthermore, manual
interactions would limit the applicability of such a system when used in a fully auto-
matic pipeline including detection and classication steps. Therefore it is desirable to
compute aortic enhancement time automatically, which requires automated detection
of the aorta in the MRI volume. In addition to this problem of user-dependency in
feature computation, we have identied a number of other weaknesses in this system.
The smart opening method used in lesion segmentation had problems in segmenting the
entire volume of large lesions with unclear margins. And the dynamic feature compu-
tation methods used incidentally produced unreasonable values in some cases, such as
negative values in starting time of enhancement and general slope of the enhancement
curve. And nally, this system was tested in a relatively small dataset and classication
performances for dierent histopathological types of cancer were not reported.
The purpose of this study is to design and evaluate a CADx system for high spa-
tiotemporal resolution DCE-MR images, which accurately computes dynamic and mor-
phological features for manually located lesions and normalizes for aortic enhancement
time automatically; therefore does not require any user interaction after semi-automated
segmentation of the lesions. We used a dataset consisting of 395 lesions (223 malignant
and 172 benign) to evaluate the diagnostic performance of the proposed system. We
compared the performance to that of the previously proposed CADx system. Addition-
ally we evaluated the performance of the designed system for three dierent types of
cancers: ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and invasive
lobular carcinoma (ILC).
2.2 Materials and Methods
2.2.1 Data Collection
Patient Population
We selected all patients scanned at our institute, Radboudumc, between 2011-2013,
who underwent a breast MRI examination, that showed a nding that was histologi-
cally sampled (either benign or malignant), or was at least one year stable based upon
MRI follow up (regarded as benign). The indications for a breast MRI in Radboudumc
include screening of women at high-risk and intermediate-risk of breast cancer, pre-
operative evaluation in women with lymph-node metastasis with an unknown primary
tumor, invasive lobular carcinoma, an invasive carcinoma under the age of 50, indeter-
minate tumor size, tumors larger than 3 cm, locally advanced carcinoma treated with
neo-adjuvant chemotherapy, and trouble shooting in women with ndings that cannot
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Table 2.1: Pathological subtypes of malignant lesions used in the study
Pathological Subtype Number of lesions
IDC 141
ILC 38
DCIS 38
Other 6
Total 223
be resolved by biopsy (BIRADS 0).
Cases in which the patient received chemotherapy before conduction of the MRI
scan were excluded from the study. We also excluded the MRI images where the
aorta of the patient was not within the eld of view. This resulted in 325 patients
and 395 lesions in total, 223 of which were pathologically proven malignant and 172
benign (117 proven by pathological nding and 55 non-biopsied benign). Benign lesion
types included in the study dataset consisted of various types, such as inamed cysts,
lymph nodes, broadenomas, adenosis and hamartoma. Histopathological types of the
malignant lesions as obtained from the pathological report of the resection specimen,
are given in Table 2.1.
DCE-MRI Acquisition
Since 2011, a bi-temporal resolution DCE-MRI acquisition protocol is used for all breast
scans at Radboudumc. This protocol is composed of a conventional DCE-MRI sequence
and a high spatiotemporal resolution TWIST (time-resolved imaging with stochastic
trajectories) sequence, using a 3 Tesla MR scanner (Siemens Magnetom Trio/Skyra, Er-
langen, Germany) with a 16-channel breast coil (Siemens). Initially pre-contrast images
are acquired with both sequences. Post-contrast images with the TWIST sequence are
acquired in the early phase of the acquisition, directly following the contrast agent ad-
ministration. Subsequently, post-contrast images with the conventional MRI sequence
are acquired every 90 seconds approximately.
Only the TWIST acquisitions were used in this study. TWIST is a view-sharing
sequence37, which divides k-space in a central region and a peripheral region, and
samples datapoints in a radial fashion. Before contrast administration the whole k-
space is sampled, which takes approximately 18 seconds. Subsequently, the central
region (A-region) of the k-space is sampled at every time-point. In the outer region
(B-region) of the k-space, a predened percentage (10% in our protocol) of datapoints
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Table 2.2: DCE-MRI Acquisition Parameters
Parameter Value
Fat Saturation No
Orientation Axial
Spatial Coverage Bilateral
Repetition Time (ms) 3.8 - 4.09
Echo Time (ms) 1.97 - 2.06
Field of View (mm) 360
Flip Angle (degree) 15 - 20
Matrix Size 384 x 384
Slice Thickness (mm) 2.5
Sequence Acquisition Time (s) 96 - 101
Temporal Resolution (s) 4.3 - 4.5
No. of image volume sets 20 (1 pre-contrast)
Size of A-region 15%
Random sampling density of B-region 10%
is replaced, while the remaining datapoints are taken from the previous time-points. It
takes about 4.3 seconds to sample the central region fully and B-region partially, which
gives the temporal resolution of the TWIST acquisitions.
Table 3.1 includes the details of the MRI acquisition. Contrast (either Gd-DOTA
(Dotarem, Guerbet, France) or Gadobutrol (Gadovist, Bayer, Germany), at a dose
ranging from 0.1 to 0.2 mmol/kg) was administered using a power injector (Medrad,
Warrendale, PA) at a ow rate of 2.5 mL/s, followed by a saline ush.
2.2.2 CADx System
The CADx system used in this study is composed of four main parts. First, the lesion
is segmented using a set of manually placed seed points. Second, the aorta is auto-
matically detected in the MR volume and the initial time of enhancement in the aorta
is computed. Third, morphological and dynamic features are computed. Dynamic
features are computed with respect to the rst time point where the aorta starts to
enhance. Finally, the lesion is classied as either benign or malignant, with a classier
trained for this purpose.
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2.2.3 Lesion Segmentation
For segmenting lesions, we extended an already developed \smart opening" algorithm
which we name as \multi-seed smart opening". In this section we rst provide a brief
description of the smart opening algorithm. A multi-seed approach, which is the one
used in this study, is described next.
Smart Opening
Smart opening is a segmentation algorithm originally developed for nodules and lesions
in CT images38. For the segmentation of breast lesions in DCE-MRI, Platel et al.36
applied this method on subtraction volumes. After the user selects a seed-point, the
smart opening algorithm begins with a 3D region growing operation. The result of this
is an initial set of voxels, N0. Holes in this initial segmentation are closed by taking
inverse of the complement of N0, denoted by N1.
The next step is a morphological opening operation, to disconnect any possibly
attached vasculatures from the segmentation. The strength of the erosion is selected
adaptively. In order to compute the erosion strength, a distance transform image is
used, which is constructed by using the minimum Euclidean distances for each voxel of
the segmented region v to the background:
E(v) := minvb jjworld(v) -world(vb)jj, (2.1)
where k...k represents the norm, world(v) are the world coordinates of the voxel of
interest v and the minimum is searched for over all background voxels vb. The distance
map is normalized by dividing all distances by the maximum distance present in the
lesion:
E(v) =
E(v)
E(v 0)
(2.2)
where v 0 is the approximate center of the lesion, found from a maximum search on E.
To nd the optimal erosion strength, all paths from the center of the lesion v 0 to the
boundary of volume of interest, that pass through voxels in N1 over a distance ridge,
are considered. Let PN1 denote the set of all paths (v0, v1, ..., vn). The optimal opening
strength  can be found from:
 = maxfminfE : v 2 pg : p 2 PN1g (2.3)
The lesion mask resulting after the erosion is denoted as N2. Then, a dilation is
performed with a slightly higher strength (+), which results in a slightly larger mask
denoted as N3. This mask contains small irregularities at the lesion boundary, but also
20 A computer-aided diagnosis system for ultrafast breast DCE-MRI
background voxels and possibly small parts of the previously removed vessels. To get
rid of the background voxels as well as any vessel segments, a nal renement step is
performed. For this purpose, the intersection I between the boundaries of N3 and N0
is computed and dilated by , resulting in I. The nal segmentation result Ns for the
selected seed-point is then dened as:
Ns = (N1 \N3)=I (2.4)
Multi-Seed Smart Opening
While the smart opening algorithm provides satisfactory segmentations in well delim-
ited rather small lesions by simply providing a seed point, the erosion strength needs be
adjusted by the user in larger lesions and lesions with not so clearly identied margins.
Unfortunately, in most of these cases, this user interaction does not lead to satisfactory
segmentations. In the present study we developed a \multi-seed smart opening" ap-
proach, which allows users to select more than one seed points, when necessary. This
brings more exibility compared to erosion strength adjustment alone.
In the multi-seed smart opening approach, the user initially places single or multiple
seed points in the lesion volume, preferably at the brightest locations of the lesion. A
smart-opening process is started from each seed point. Erosion strength is adjusted
automatically in each smart opening process. Let k be the number of seed points
placed by the user and Nsi be the segmentation resulting from the i
th seed point.
Then;
Nf = (Ns1 [Ns2 ... [Nsk), (2.5)
where Nf, union of all the resulting regions, is the nal segmentation mask of the
multi-seed smart opening algorithm. If the segmentation result is not satisfactory, the
user can add or remove the seed points and restart the process. In this study, we
ran this segmentation algorithm on the subtraction images of the last post-contrast
image and the pre-contrast image of the TWIST series. Fig. 2.1 shows an example for
which segmenting the whole non-mass-like lesion was not possible with smart opening
algorithm, but it could be achieved with the multi-seed smart opening method.
2.2.4 Feature Computation
Morphological Features
Based on the segmentation mask of the lesion, ve morphological features were com-
puted for each lesion:
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Figure 2.1: Views of segmentations for a non-mass like lesion. Segmenting the whole lesion was not
possible with the smart opening algorithm (middle), where the whole lesion could be segmented with
the multiseed smart-opening algorithm (right).
 Margin Gradient (MG)
MG = maxi=0,1,...,T-1

meanrjjr[Fm(r, i) - Fm(r, 0)]jj
meanrFm(r, i)

, (2.6)
where Fm(r, i) is the set of intensity values in the lesion margin at time-point i,
r is the gradient operator, T is the number of time-points in the DCE series and
the range of vectors r is limited to a three-voxel thick shell centered on the surface
of the lesion.
 Margin Variance (MV)
MV =
variancerjjr[Fm(r, i) - Fm(r, 0)]jj
[meanrFm(r, i)]2
, (2.7)
where i is the time-point selected in MG computation.
 Circularity (C)
C =
Vinsphere
V
, (2.8)
where V is the volume of the lesion and Vinsphere is the volume of the sphere
with a diameter deff, which is computed by the formula:
deff = 2  3
r
3  V
4
, (2.9)
 Irregularity (IR)
IR = 1-
  d2eff
A
, (2.10)
where A is the surface area of the lesion.
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 Radial Gradient Analysis (RGA)
RGA = maxi=0,...,T-1fvariancepifH(pi)gg, (2.11)
whereH is the histogram of pi, which refers to the radial gradient values computed
at time-point i. In order to compute the radial gradient values, a rectangular box
is drawn around the lesion and imaginary lines are drawn from the center of this
box outward. The radial gradient values are calculated as the normalized dot
products of the these radial vectors rc and the local gradient vector:
pi =
jr[Fb(r, i) - Fb(r, 0)]  (r- rc)j
jjr[Fb(r, i) - Fb(r, 0)]jj  jj(r- rc)jj , (2.12)
where r[Fb(r, i) - Fb(r, 0)] indicates the set of intensity gradients in the box at
the subtracted timepoints i and 0.
These well-known morphological features were commonly employed in previous stud-
ies36,39{41 and they correspond to the morphological properties used in the BI-RADS
system35. Margin gradient and variance are measures of how well-dened the bound-
aries of a lesion is, where circularity and irregularity features dene the shape of a
lesion. A similar analysis to the RGA described here was applied to mammography
images before, in order to quantify how spiculated the lesions are42. Since malignant
lesions typically extend in less spherical and more spiculated patterns, malignant lesions
are expected to have lower RGA values than benign lesions.
Dynamic Features
Six dynamic features were computed for each voxel within the lesion based on their
contrast agent uptake curves. These features are:
 maximum slope (MS)
 time of maximum slope (TMS)
 time to enhancement (TTE)
 nal slope (FS)
 general slope (GS)
 maximum enhancement (ME)
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The feature MS is known to be higher in malignant lesions compared to benign from
previous work15. Also, how fast enhancement of a lesion occurs has been found to be
indicative of malignancy43, which is related to the features TMS and TTE. The other
three features FS, GS and ME are thought to be representative of the features which
are commonly used in conventional DCE MRI analysis. FS is similar to the \washout"
feature (or \curve type") and the lesions showing low or negative slope at the end of
this early phase are expected to have malignant behavior. The ME feature represents
the maximum enhancement and GS is similar to the \uptake rate" feature which are
both used in conventional DCE-MRI analysis.
Before computing the dynamic features, the intensity curves of each voxel were tted
using a logistic model44 given in Eq. 2.13.
s(t) = P1 +
P2 + P5  t
1+ e-P4(t-P3)
(2.13)
For curve-tting, the \MINPACK-1 Least Squares Fitting Library" was used in
C++, which implements the Levenberg-Marquardt algorithm45.
The dynamic features were computed based on the relative enhancement curve,
which is dened as
r(t) =
s(t) - s(0)
s(0)
 100%, (2.14)
where s(0) and s(t) are the voxel intensity value before contrast agent injection and voxel
intensity value at the given time t, respectively, as determined by the tted curve.
An illustration of a tted curve and the dynamic features computed based on this
curve is given in Fig. 2.2. While these features were previously introduced by Platel et
al.36, we followed a dierent approach in computing these features. The rst dierence
is in computation of relative enhancement values. In this study we perform curve-tting
directly on intensity values, and then we compute the relative enhancement curve based
on the tted curve, rather than following the opposite order. The main idea here is to
use the advantage of curve-tting to reduce the noise in pre-contrast intensity values,
which has a direct eect on the features computed. Additionally we changed the way
of computing TTE and GS features, since the previous approach incidentally produced
negative values in some of the cases. The formulas used to compute the dynamic
features are given below:
MS = max r 0(t) (2.15)
TMS = argmaxtr
0(t) - tAorta (2.16)
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Figure 2.2: An example for a tted cuve and the features computed based on this curve.
TTE = argmaxtr
00(t) - tAorta (2.17)
FS = r 0(T) (2.18)
GS = max
r(t) - r(tAorta)
t- tAorta
(2.19)
ME = max r(t) (2.20)
The rst and second derivatives of the relative enhancement function r are denoted
by r 0 and r 00, respectively. The time at which the aorta starts to show enhancement is
dened as tAorta. This value is automatically acquired from the aorta in the image as
described in Sec. 2.2.6. The last time instance of the acquisition is dened by T .
After computing these features for each voxel, averages and standard deviations of
each feature were computed in the segmented region. In addition to these, a smaller
region of interest that represents the most suspicious region (MSR) within the lesion
was selected automatically (see Sec. 2.2.5). The average values of the dynamic features
were also computed for the MSR. In total, 18 dynamic features were computed for each
lesion.
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2.2.5 Most Suspicious Region Selection
A method was developed to automatically select a small region of interest within the
entire segmented region, where enhancement patterns are most suspicious for malig-
nancy. We refer to this region as the \most suspicious region" (MSR) and similar to
the BI-RADS system35, we dene it to be consisting of at least three connected voxels.
Feature maps of MS and ME were used to select this region. For both maps, initially a
threshold was applied at the 99.9 percentile. Then, a binary volume was created based
on the intersection of the two thresholded maps. Connected component analysis was
applied to nd a 3D connected component (with 6-connectedness) consisting of at least
three voxels. If there was no such region, the threshold was lowered by 0.1% iteratively,
until a connected component of at least three voxels was found. This yields a small
connected region showing a high MS and ME, which was selected as the MSR.
2.2.6 Automatic Aorta Detection and Computation of Aortic Enhancement
Time
As described in Sec. 2.2.4, time of initial enhancement in the descending aorta is used
as the starting point of the uptake curve while computing the dynamic features. We
automated computation of this value in our CADx system. In order to do this, we rstly
detect the location of the aorta automatically and select a representative region in the
aorta. In the second step, the average enhancement curve of this region is computed.
Finally, the initial enhancement time of this curve is calculated.
The process illustrated in Fig. 2.3 summarizes the aorta detection pipeline. In order
to increase the contrast of the aorta with respect to non-enhancing parts of the body, we
used subtraction images obtained by subtracting the maximum and minimum intensity
values of the voxels through time. Detailed description of the steps of aorta detection
are given below:
1. Initially median ltering was applied to the subtraction image. Median lter is
selected here since it removes the noise while maintaining the edges46.
2. The descending aorta is almost a cylindrical structure, extending perpendicular
to the axial planes. Because of this property, a circle is visible in each axial
plane of the subtraction image where the descending aorta is present. We used
a Hough47,48 transform lter here to detect the circles in all axial slices. Since
the size of the aorta is relatively consistent between the patients, we used a single
xed radius of 10 mm in the Hough transform for all of the images.
3. Since the cylinder-like structure of the descending aorta extends through several
axial planes, 3D combination of Hough-transformed slices generates a vessel-like
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Figure 2.3: An illustration of the pipeline applied for automatically determining the time of aortic
enhancement in TWIST DCE-MRI of the breast. The image on the left is an example subtraction image
in axial view, acquired by subtracting maximum and minimum intensity through time images. The
aorta is indicated by the arrow. For steps 2, 3, 4 and 5 in the aorta detection pipeline, corresponding
example outputs in sagittal view are given at the left side of the steps. The uptake curve of the
representative part of the aorta is seen at the right side, together with the tted curve. The initial
rising point of this curve is selected as tAorta.
structure at the location of the aorta in the axial direction. Therefore a vesselness
lter49 was applied to the 3D image formed after the Hough transforms.
4. A threshold was applied on the vesselness image, selecting the 1% most vessel-like
voxels.
5. After applying this threshold, it is possible to end up with more than one con-
nected component in some cases. In this case, we selected the largest one and
at most two others that are more than 70% of the size of the largest connected
component. The nal selection is based on the location: location of the aorta is
always at the backside of the other organs, breast, pectoral muscle and the heart.
Therefore the connected component having voxels furthest in dorsal direction is
selected. The single voxel with the highest vesselness value within the connected
component, was selected as the location of the aorta.
After locating the aorta, a 9mm2 region around this location in the axial plane was
selected to obtain an average uptake curve. This size was experimentally selected to
make sure it is small enough not to extend to outside of the aorta, but large enough to
make an average to reduce the variance. The obtained aortic uptake curve was tted to
a logistic model given in Eq. 2.21, which is similar to the model used for uptake curves
of the lesions:
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sA(t) = P1 +
P2 + d(t)
1+ e-P4(t-P3)
(2.21)
where
d(t) =
P6
1+ et-(P3+P5)
(2.22)
The dierence of the model used for the aortic uptake curve given in Eq. 2.21 to the
lesion uptake curve given in Eq. 2.13 is about modeling the later part of the curve. In
Eq. 2.13, the model parameter P5 models the nal slope of the lesion uptake curve
44.
But this is not directly applicable to the aortic uptake pattern, since the aorta enhances
early and fast, which is followed by a decay to a constant enhancement. An example is
given in Fig. 2.3. In order to model the decay at the later part of the aortic enhancement
curve, we replaced the parameter P5 by an exponential decay d(t) (see Eq. 2.22). P3 in
this model is related to the start of enhancement, similar to the lesion uptake curve44.
P5 is related to how much time passes between the start of enhancement and the start
of the decay. And P6 is related to the strength of the decay. It must be noted that
the decay part of the aortic enhancement is not related to the task of nding the aortic
enhancement time, but this part was included in the model in order to reduce the mean
error of the curve-tting and therefore to make it more stable.
After the aorta uptake data was tted to the model, tAorta was computed by obtain-
ing the maximum of the second-order derivative:
tAorta = argmaxts
00
A(t) (2.23)
2.2.7 Experiments and Evaluation
Classication
For classication we used the random forests algorithm, because we have a high dimen-
sional feature space consisting of 23 features in total and the random forests algorithm
incorporates a type of greedy feature selection50. We set the maximum number of trees
in random forests classier to 1000 and maximum tree depth to the number of features.
We performed a receiver operating characteristic (ROC) analysis in a leave-one-out
cross validation scheme. We used the area under the ROC curve (AUC) to evaluate
the classication performances. For each leave-one-out iteration, we prevented lesions
of the same patient to be present in both training and test set. We used the resulting
probabilistic outputs in the publicly available ROC-kit software51 in order to generate
the ROC curves, to compute AUC values with condence intervals and to compare
the AUC values of the ROC curves. Dierences in AUC values were considered as
signicant when p-values were smaller than 0.05.
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We performed 3 sets of experiments to evaluate the classication performance of the
presented CADx system:
1. We performed classication using all features. Then, we repeated this for only
dynamic features and only morphological features. We plotted the smoothed ROC
curves produced by the ROC-kit software.
2. We measured classication performance of the CADx system individually for three
dierent cancer types: DCIS, IDC and ILC. In order to construct the ROC curves
for each histopathological type, we directly used the probability outputs of the
corresponding lesions and all benign lesions, which were generated during the
previous classication processes in leave-one-out setting.
3. The performance of the presented CADx was compared to that of the previous
CADx system36 on our dataset.
Multi-Seed Smart-Opening Algorithm
In order investigate the eect of subjectivity involved in manual selection of seed-points
and robustness of the algorithm with respect to variations in this respect, we conducted
two experiments:
1. We randomly shifted the location of each manually placed seed-point to a location
within 1 to 2.5 mm distance from the original location in 3D. We selected 2.5 mm
as the maximum distance to make sure that it is possible to shift location also in
axial slices, as this is the slice thickness of the images used.
2. For the lesions containing multiple seed point (n=142), half of the seed-points
were randomly removed. (In case of an odd number of seed-points, the number
of seed-points remaining was rounded up.)
For each experiment we computed the dice similarity coecient (DSC) values of the
overlap of the original and randomly modied segmentations. We reported average
and standard deviation of DSC values. We also repeated classication process for the
randomly modied segmentations of each experiment. We reported AUC values and
we compared them to the AUC values that resulted from the original segmentations.
Automated Aorta Detection
In order to evaluate the overall accuracy of automated aorta detection, we manually
segmented the descending aortas in all of the images used in the study. On an in-house
developed workstation, we made manual drawings in the rst and last axial planes in
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Table 2.3: AUC values for three dierent cancer types
Morphological Dynamic All
DCIS 0.7270 (0.6316-0.8083) 0.7690 (0.6728-0.8469) 0.7924 (0.7017-0.8644)
IDC 0.7452 (0.6872-0.7970) 0.8459 (0.7969-0.8893) 0.8688 (0.8247-0.9046)
ILC 0.7741 (0.6912-0.8427) 0.8673 (0.8018-0.9161) 0.8650 (0.7965-0.9158)
which the aorta is visible. We added manual drawings in some of the intermediate
axial planes when it was necessary for an accurate aorta volume generation. Then, the
workstation generated the aorta segmentation volume by interpolating between these
manual drawings.
As a measure of the overall performance of the aorta detection system, we counted
the number of MRI scans for which aorta detection failed to locate the aorta inside the
provided manual segmentation of the aorta.
Additionally, we performed experiments in order to observe the eect of the se-
lected parameters, and to evaluate the robustness of the method with respect to those
parameters. We made this evaluation for the radius parameter of the Hough transform
and the threshold level applied to the vesselness image in a sequential way. We rstly
xed the Hough radius parameter to 10 mm, and we varied the vesselness threshold
with percentile values at 0.1, 0.5, 1, 2 and 5. Then, we xed the vesselness threshold
parameter to 1% and we varied the Hough radius parameter with values 6, 8, 9, 10, 11
and 12 mm. For each parameter set we repeated aorta detection process for all MRI
scans and we reported the number of MRI scans for which automated detection failed
to locate the aorta within the manually segmented aorta volume.
2.3 Results
2.3.1 Classication
Fig. 2.4 shows the ROC curves of the CADx system presented in this study, where
morphological and dynamic features were used together, and separately. The AUC value
was 0.8543 when all features were used. When morphological and dynamic features were
used separately, the AUC values were 0.7556 and 0.8406, respectively.
AUC values for three dierent histopathological cancer types are given in Table 2.3.
The AUC value for the previous CADx system36 was measured as 0.8172 with all
available features, when the dataset from the current study was used. Fig. 2.5 shows a
comparison of the ROC curves of the two CADx systems based on the same dataset of
the current study. The CADx system presented in this study obtained a signicantly
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Figure 2.4: ROC curves for benign/malignant classication based on morphological, dynamic and all
features in the CADx system developed in the present study.
Table 2.4: AUC values of the ROC curves of the two CADx systems
Morphological Dynamic All
Previous CADx 0.7387 (0.6882-0.7847) 0.7972 (0.7513-0.8376) 0.8172 (0.7732-0.8555)
Presented CADx 0.7556 (0.7060-0.8002) 0.8406 (0.7994-0.8758) 0.8543 (0.8147-0.8878)
Two-tailed p-values 0.4015 0.0053 0.007
higher AUC value (p=0.007). Table 2.4 shows the comparison of the AUC values when
morphological, dynamic and all features were used in the presented CADx and the
previous CADx systems.
2.3.2 Multi-Seed Smart-Opening Algorithm
In the rst experiment, when the seed-points were shifted randomly, the average DSC
value between the modied segmentations and the original segmentations was 0.85
(0.16). When classication was repeated based on these segmentations with all fea-
tures, the AUC value was 0.8416, which was not signicantly lower than the AUC value
obtained from the original segmentations (p=0.1469).
In the second experiment, when half of the seed-points from lesions with multiple
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Figure 2.5: ROC curves for benign/malignant classication when all features were used in the presented
and previous CADx systems.
seeds were randomly removed, the average DSC value between the modied segmen-
tations and the original segmentations was 0.88 (0.19). When the classication was
repeated based on these segmentations, the AUC dropped to 0.8339, which was signi-
cantly lower than the AUC value obtained from the original segmentations (p=0.0362).
2.3.3 Automated Aorta Detection
The aorta detection algorithm developed in this study was able to correctly locate the
aorta in all the 325 TWIST DCE-MRI examinations used in this study when 10 mm
radius was used in the Hough transform and 1% threshold was used on the vesselness
image. When the Hough radius was xed at 10 mm and the threshold on the vesselness
image was selected as percentiles at 0.1, 0.5, 1, 2 and 5, the numbers of failed aorta
localizations were 1, 0, 0, 1 and 2 respectively. When the threshold on vesselness was
xed at 1% and the Hough radius was selected as 6, 8, 9, 10, 11 and 12 mm, the numbers
of failed aorta localizations were 67, 11, 0, 0, 3 and 22 respectively.
2.4 Discussion
In this study, we developed a CADx system for classifying lesions in high spatiotempo-
ral resolution DCE-MRI of the breast. The CADx system was applied to a consecutive
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dataset of 395 lesions (223 malignant, 172 benign) obtaining an AUC value of 0.8543
for benign/malignant classication of breast lesions. When morphological and dynamic
features were used separately, AUC values were 0.7556 and 0.8406 respectively. Clas-
sication performances were acceptable for all of the three histopathological types,
while it was lowest for DCIS lesions (Table 2.3). This was an expected result, since
several studies have repeatedly shown that it is more dicult to dierentiate DCIS
lesions from benign lesions in DCE-MRI compared to dierentiating invasive lesions
from benign40,52{54. This can be explained by less vascular development existing in
DCIS cancers compared to invasive cancers15,55.
The presented CADx system signicantly outperformed a previously developed
CADx system36 (p=0.007), while being more user independent. The improvement in
classication performance can be explained by three factors: improved segmentation,
automated aortic enhancement time computation and improved dynamic evaluation.
Multi-seed smart opening produced lesion segmentations that covered the entire lesion
volume, while this was not possible for some of the lesions with single-seed smart open-
ing algorithm. Although this aected the performance of morphological classication
only by about 1% in the AUC, it also has an eect in evaluation of the dynamic char-
acteristics and heterogeneity (standard deviation of the features) of the lesion, since
these are evaluated within the segmented volume. The second contribution comes from
the automated aortic enhancement time computation. The previous approach of man-
ually determining the aortic enhancement time involves subjectivity and its accuracy
is limited by the temporal resolution of the acquisition, which is 4.3 seconds in this
study. The automated method developed in this study is objective and the algorithm
is able to estimate values in an interpolated time domain, based on the tted function.
The third improvement comes from the dynamic feature computation. We initially
tted the intensity curve and then computed relative enhancement curve based on the
tted function, rather than doing the curve-t on relative enhancement values. In this
way, we used the tted curve to obtain pre-contrast intensity value, preventing noise
in the pre-contrast image to propagate as errors to the dynamic feature computation
steps. Another dierence in dynamic evaluation was in computation of TTE, where
we used the maximum of the second-order derivative, instead of the curvature formula
used in the study by Platel et al36. Since the curvature values were very sensitive to
small changes in the curve shape, often resulting in negative TTE values, we preferred
using the maximum of the second-order derivative, similar to the approach followed by
Moate et al44. And lastly, we did not use the second vertex point for computing the GS
feature, since some lesions continue enhancing persistently and do not have this point
in their uptake curves. Therefore, we followed a dierent approach, which is not based
on the second vertex point, to make computation of this feature more stable.
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When the comparison to the previous CADx system was done based on morphology
or kinetic features separately, it was seen that the improvement in morphological eval-
uation was not statistically signicant (p=0.4015), while it was statistically signicant
for the kinetic features (p=0.0053), as given in Table 2.4. The nding that morpholog-
ical evaluation was not improved signicantly despite of the changes in segmentation
might be related to the morphological features that we used. In this work, we used the
same 5 features which were also used in the previous study36. It might be possible to
achieve a higher classication accuracy by using a more extensive feature set. This can
be investigated in a future study.
The multi-seed smart opening algorithm was found to be robust against small (1-2.5
mm) variations in seed-point locations. A random shift on the locations caused only
1% drop in the AUC value, which was not statistically signicant. The drop in the
AUC value was larger when randomly selecting half of the seed-points in lesions with
multiple seeds. This is an expected result, since placing additional seeds for some of
the lesions improves segmentation, as previously explained in section II.C.
The aorta detection method developed in this study was able to detect the locations
of the aorta correctly for all of the 325 cases, by using the unique anatomic and en-
hancement characteristics of the aorta. Results of the experiments on the parameters
of the algorithm showed that, the algorithm was robust against selection of the thresh-
old level on the computed vesselness image, while selection of the radius parameter in
the Hough transform was critical. The selection of 10 mm radius produced the best
results, without any failure in aorta localization. This is most probably due to the
relatively consistent radius of the aorta. The average radius of the descending aortas
in the images used in this dataset was computed to be 10.3mm(1.3mm), based on
the manual segmentations, which excluded the wall thickness of the aorta due to the
absence of contrast enhancement in that region. This value is consistent with a pre-
vious study56 by Wolak et al. where average descending aorta radius was found to
be 11.3mm(1.1mm), considering that this diameter measurement included the wall
thickness of the aorta, which is expected to be about 0.61mm57. In the future we plan
to study the use of computer-aided detection systems in order to fully automatize the
task for detection, segmentation and diagnosis of breast lesions. The suspicious regions
in the volume given by a computer-aided detection system, such as the one described
by Gubern-Merida et al.27, could be used as input seed points to initiate the CADx
system. Reducing the required user interactions by automatizing the detection of aorta
is an important step towards this direction.
One limitation of our study is that we did not use pharmacokinetic analysis, but
we directly used relative enhancement curves to compute the dynamic features. Rela-
tive enhancement values might be aected by MRI acquisition parameters and contrast
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agent dose administered to the patient. However, our dataset contains patients scanned
with various contrast agents, using varying doses and a slight variability in MRI ac-
quisition parameters. The acceptable performance in classication achieved with this
dataset supports the feasibility of using curve features without doing pharmacokinetic
analysis. Although a pharmacoknetic analysis might further improve this performance,
this would require an accurate T1 mapping of the breast and a patient specic arterial
input function. Accurate T1 mapping requires additional scans to be obtained and is
thus less optimal in a fast scan protocol. The calculation of a patient specic arterial
input function has repeatedly been shown dicult; and if the input function is not ro-
bust, the variability of `quantitative' pharmacokinetic parameters may be even higher
than when using the heuristic approach performed in this study.
In conclusion, we developed a CADx system for high spatiotemporal resolution
DCE-MRI of the breast. Our system requires initial seed points to be located by
the user, after which it automatically segments, characterizes and classies the breast
lesions into malignant and benign classes. It also includes automatic aorta detection
and aortic enhancement time computation, which are required for the dynamic feature
computations. We evaluated this system in a dataset of 395 lesions. The presented
system obtained a satisfactory performance and signicantly outperformed previously
developed systems.
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Abstract
Purpose: Automated segmentation of breast and broglandular tissue (FGT) is required
for various computer-aided applications of breast MRI. Traditional image analysis and
computer vision techniques, such atlas, template matching or edge and surface detection
have been applied to solve this task. However, applicability of these methods is usually
limited by the characteristics of the images used in the study datasets, while breast MRI
vary with respect to the dierent MRI protocols used, in addition to the variability
in breast shapes. All this variability, in addition to various MRI artifacts makes it
a challenging task to develop a robust breast and FGT segmentation method using
traditional approaches. Therefore, in this study, we investigated the use of a deep
learning approach known as `U-net'.
Methods: We used a dataset of 66 breast MRI's randomly selected from our scientic
archive, which includes ve dierent MRI acquisition protocols and breasts from four
breast density categories in a balanced distribution. In order to prepare reference
segmentations, we manually segmented breast and FGT for all images by using an
in-house developed workstation. We experimented with the application of U-net in
two dierent ways for breast and FGT segmentation. In the rst method, following
the same pipeline used in traditional approaches, we trained two consecutive (2C) U-
nets; rst for segmenting the breast in the whole MRI volume, and the second for
segmenting FGT inside the segmented breast. In the second method, we used a single
3-class (3C) U-net, which performs both tasks simultaneously by segmenting the volume
into three regions: non-breast, fat inside the breast and FGT inside the breast. For
comparison, we applied two existing and published methods to our dataset: an atlas-
based method and a sheetness-based method. We used Dice Similarity Coecient
(DSC) to measure the performances of the automated methods, with respect to the
manual segmentations. Additionally, we computed Pearson's correlation between the
breast density values computed based on manual and automated segmentations.
Results: The average DSC values for breast segmentation were 0.933, 0.944, 0.863
and 0.848 obtained from 3C U-net, 2C U-nets, atlas-based method and sheetness-based
method, respectively. The average DSC values for FGT segmentation obtained from
3C U-net, 2C U-nets and atlas-based methods were 0.850, 0.811 and 0.671, respectively.
The correlation between breast density values based on 3C U-net and manual segmen-
tations was 0.974. This value was signicantly higher than 0.957 as obtained from 2C
U-nets (p<0.0001, Steiger's Z-test with Bonferroni correction) and 0.938 as obtained
from atlas-based method (p=0.0016).
Conclusions: In conclusion, we applied a deep learning method, U-net, for segment-
ing breast and FGT in MRI in a dataset that includes a variety of MRI protocols and
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breast densities. Our results show that U-net based methods signicantly outperformed
the existing algorithms and resulted in signicantly more accurate breast density com-
putation.
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3.1 Introduction
Automatic segmentation of breast and broglandular tissue (FGT) is a key step in auto-
mated analysis of breast MRI for several clinically relevant applications. One example is
computer-aided detection (CADe) systems which use breast segmentation as an initial
step to determine the region to search for lesions27,58,59. Automated quantication of
background parenchymal enhancement (BPE) could be considered as another example
to the applications which require FGT segmentation, since BPE is evaluated within
FGT60. More importantly, volumetric measurement of breast density in MRI requires
segmentation of breast and FGT61{65. Breast density, measured by the amount of FGT
relative to the breast volume, is a strong predictor of breast cancer risk66{68. Although
breast density is often measured based on mammograms, these are two dimensional
projection images which may lead to inaccuracy in estimation of breast density, due
to the tissue superimposition69. T1-weighted images in breast MRI provides three-
dimensional (3D) information with a strong contrast between fat and broglandular
tissues within the breast, making it ideal for evaluating breast density. For an objective
evaluation of breast density based on MRI, automatic segmentation of breast and FGT
is required.
Breast segmentation consists of breast-air and breast-pectoral muscle separation,
where the latter is usually considered to be a challenging problem. There have been
several studies investigating breast segmentation in MRI. Nie et al.61 developed an
algorithm to segment breast and FGT, using B-spline curve tting for pectoral muscle-
breast separation, which required initial inputs from the user. Milenkovich et al.70
proposed a fully-automated method by using edge maps obtained by applying a tunable
Gabor lter and they reported 0.96 for the average Dice similarity coecient71 (DSC)
value for 52 MRIs. Koenig et al.72 developed a method which uses nipple detection as a
prior step. Martel et al.73 used Poisson reconstruction method to dene breast surface
using automatically detected edges, achieving a DSC score of 0.90 for 332 Dixon images
and 0.96 for 8 T1-weighted images. Similarly, Gallego-Ortiz et al.74 suggested a method
that aims to construct breast surface, and they used a breast atlas. They reported a
DSC value of 0.88 for a large dataset consisting of 409 MRIs. Atlas-based methods
were also employed by Khalvati et al.75 (obtaining average DSC scores of 0.94 for
Dixon and 0.87 for T1w images), Lin et al.76, and Gubern-Merida et al.65,65 (obtaining
an average DSC of 0.94 in 50 MRIs). Pectoral muscle-breast boundary separation in
the latter method was based on automatic detection of sternum as a landmark which is
not always clearly visible in all patients. Wang et al.77 suggested a method which uses
sheet-like appearance of pectoral muscle boundary and does not require detection of a
landmark. Giannini et al.78 used gradient characteristic of pectoral muscle to separate
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it from breast. Ivanovska et al.64 suggested a level-set method to simultaneously correct
bias-eld and segment breast, which achieved an average DSC of 0.96 in 37 MRIs.
Several studies have also investigated FGT segmentation. Although MRI provides a
high contrast between fat and FGT in breast, intensity inhomogeneities introduce the
main diculty in FGT segmentation. Adaptive fuzzy c-means (FCM) was used by Nie
et al.61 for FGT segmentation. Gubern-Merida et al.65 used N4 bias-eld correction79
as a prior step to their their pipeline and then applied a gaussian mixture model for
segmenting FGT, which resulted in an average DSC of 0.80 in 50 MRIs. At a later
study we extended this work by adding an additional N4 bias-eld correction step
applied within the computed breast mask for each breast60 and obtained a DSC value
of 0.81 on 20 breast MRIs. In another study simultaneous FCM and bias-eld correction
methods were applied64, which achieved an average DSC of 0.83 on 37 cases. Wu et
al.62 suggested use of FGT atlas as a renement step after FCM and reported 0.77 as
average DSC value. As post-processing steps, Gubern-Merida et al.65 and Ravazi et
al.80 also proposed methods for removing skin-folds from the segmentation, an imaging
artifact that mimics FGT. An average DSC of 0.84 was reported in the latter work.
Although the studies summarized above reported satisfactory results within their
datasets, applicability of these methods is usually limited by the characteristics of the
images used in the study datasets. However, breast MRI varies with respect to dif-
ferent MRI protocols used. Even in a single hospital, a variability would be expected
in MRI data across years, since protocols are changed from time to time due to the
improvements in acquisition or MRI units. In addition to the variability in MRI pro-
tocols, there is also variability in breast shapes, sizes, densities, and pectoral muscle
shapes. Another problem is the MRI artifacts such as intensity inhomogeneities, ghost-
ing or aliasing eects. Skin folds may also occur which mimic the appearance of FGT.
For each of such artifacts, a separate algorithm or lter is needed to be designed and
included in the segmentation process. Even then, strength and presentation of these
artifacts vary with respect to breast shapes, acquisition protocols or patient movements
during the acquisition. All this variability and artifacts make it a challenging task to
develop a robust and widely applicable breast and FGT segmentation method using
traditional approaches. Therefore, we decided to investigate the use of deep learning
methods for breast and FGT segmentation as an alternative to the traditional methods.
The main advantage of the deep learning methods lies in their ability to learn relevant
features and models directly from examples, rather than requiring design of features or
lters specic for each problem. Although it has a longer history, deep convolutional
neural networks have attracted a considerable attention in the last few years due to
the groundbreaking success it demonstrated in various elds such as image and speech
recognition, natural language understanding, and lately, in medical image analysis eld.
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In this study we investigated two deep learning approaches based on the U-net archi-
tecture81 for breast and FGT segmentation in MRI. To our knowledge, this is the rst
study that applies deep learning for breast and FGT segmentation in MRI.
One advantage of U-net is that it is possible to use entire images of arbitrary sizes,
without dividing them into patches. This results in a large receptive eld that the
network uses while classifying each voxel, which is important in segmentation of large
structures like the breast. In order to represent the variety mentioned above, we used
MRI scans obtained by dierent acquisition protocols and breasts from dierent breast
density categories in our dataset. We reported segmentation performance of the trained
U-nets for each beast density category and for each MRI protocol, as well as the overall
performance. For comparison, we also applied two dierent existing methods65,77 on
our datasets.
3.2 Materials and Methods
3.2.1 Patient Population and DCE-MRI Acquisition
At the Radboud University Medical Center, Nijmegen, the Netherlands, breast MRI
is performed for screening women with intermediate or high risk for developing breast
cancer; for preoperative staging in women with an invasive lobular carcinoma, an in-
vasive carcinoma under the age of 50, indeterminate tumor size, tumors larger than
3 cm, locally advanced carcinoma treated with neo-adjuvant chemotherapy; for trou-
bleshooting in women with ndings that cannot be resolved by biopsy (BIRADS 0) and
for evaluation in women with lymph-node metastasis with an unknown primary tumor.
For this study, we randomly selected 66 breast MRI examinations from dierent women
(ages 25-75) that had no history of breast cancer. In order to cover a large variability
of MRI protocols and breast sizes, we intentionally included scans acquired in a long
time span (from 2000-2015) from women at dierent breast density categories. For 53
of the patients, breast density scores were measured on the mammograms that were
acquired within 6 month prior to the MRI, with the Volpara software method (version
1.5.0; Volpara Health Technologies, Wellington, NZ). Accordingly, 10, 14, 14 and 15
women were categorized in breast density categories 1, 2 ,3, and 4, respectively (1 is
the least and 4 is the most dense). Volpara scores were not available for the remaining
13 cases. For some of these patients there were no mammography studies close to the
date when the MRI was scanned (mammograms were acquired in another period of the
year or, for women younger than the age of 35, they were not acquired at all). For the
other patients only processed mammograms were available, while Volpara requires raw
mammograms to compute density.
In our study dataset, there was a variability in MRI acquisition parameters, since
3.2 Materials and Methods 41
Table 3.1: DCE-MRI Acquisition Parameters for each protocol (Pr.)
Pr. 1 Pr. 2 Pr. 3 Pr. 4 Pr. 5
Number of MRI's 27 17 4 13 5
Field Strength (Tesla) 1.5 3 3 3 3
Orientation Coronal Coronal Axial Axial Axial
Flip Angle 20 13 10 20 15
Echo Time (ms) 4 2.36-2.41 1.71 2.06 1.71
Repetition Time (ms) 7.8 7.35 4.56 5.03 5.5
Resolution-X (mm) 0.66 0.88-1.0 0.8 0.8 0.8
Resolution-Y (mm) 1.3 1 0.8 0.8 0.8
Resolution-Z (mm) 0.66 0.88-1.0 1.0 1.0 1.0
Field Of View-X (mm) 340 340-380 360 360 360
Field Of View-Y (mm) 156 160 360 360 360
Field Of View-Z (mm) 170 170-190 176 160 176
we selected images from an image archive that covers a large time period. Twenty
seven of the 66 MRI's were acquired in 1.5 Tesla (T) MRI units, while 3T was used
in the rest. The MRI's acquired in 3T also varied in acquisition parameters. We have
grouped these acquisition parameters into 5 protocols (Pr.) and details are given in
Table 3.1. Note that the symbols X, Y and Z denote the directions corresponding to
the directions orthogonal to the saggital, coronal and axial planes, respectively. All of
the images used in this study were non-fat-suppressed T1-weighted images.
3.2.2 Manual Segmentation
For each MRI, we manually generated reference breast and FGT segmentations, by
using an inhouse-developed workstation. These manual segmentations were performed
by a trained biomedical engineer and were revised and validated by a breast radiologist
with 9 years of expertise in breast MRI.
For manual breast segmentation, we manually delineated each breast by drawing
contours in several axial slices. The workstation automatically interpolated between
these contours and generated mask of the whole breast volume. The annotator could
interactively add more contours between slices when the result of the interpolation was
not satisfactory. The interpolation algorithm uses a spline surface function out of the
path points of the contours, and scans the missing slices in between by a marching
squares algorithm.
For FGT segmentation, we used manual thresholding to select FGT voxels. First,
in order to reduce the eect of bias-eld, we applied N4 bias-eld correction using the
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breast segmentation mask obtained in the previous step. Then, we manually selected a
threshold value for the whole breast to select FGT voxels. Finally, we applied additional
manual corrections where necessary. These manual corrections included modifying the
threshold value for individual slices, and manually excluding some of the regions by
drawing contours.
3.2.3 Data Pre-processing
We initially re-oriented all coronal acquisitions into axial orientation. Since two breasts
of a patient are often symmetric, we approached the segmentation problem as a seg-
mentation task for a single breast. Therefore we divided each breast MRI scan into two
breast volumes, each one including one breast (right and left). This could be performed
safely by dividing the volume from the middle, since the use of a dedicated breast coil
and positioning of the patients in MRI units ensure that right and left breasts always
appear in their respective right and left halves in the MRI scan. After this division, we
mirrored the left breasts so that they appear similar to the right breasts. This action
was performed to facilitate the learning process, thus the network only needed to learn
the shape variations of the right side. The segmentation task was then performed for
both right and mirrored left breasts. We did not apply any further pre-processing to
the data.
3.2.4 Deep Learning Network Architectures and U-net
Deep learning methods are dened by LeCun et al.33 as \representation-learning meth-
ods with multiple levels of representation, obtained by composing simple but non-linear
modules that each transform the representation at one level (starting with the raw input)
into a representation at a higher, slightly more abstract level.". The main idea behind
this approach is that it is possible to implement very complex functions by using con-
volutional neural networks with several layers, each having non-linear output layers.
Each of these layers transform the representation of the data (image) at their input
to a higher level of representation. The advantage of this approach is, the weights
in the network are learned by examples through iterations of gradient-descent based
algorithms, leaving no need for engineering features for specic problems.
A patch-based approach is commonly employed in deep learning, where images are
divided into small patches of certain sizes and provided to the network. However, this
approach limits context information provided to the network, as the receptive eld
of these networks are limited to the patch size. Increasing the patch size to increase
contextual information is not always the best solution because training might then
become computationally infeasible. The advantage of convolutional networks with U-
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net81 architecture is that it is possible to use entire images of arbitrary sizes, without
dividing them into patches. This results in a large receptive eld that network uses
while classifying each voxel, which is important in segmentation of large structures
like the breast. Therefore, we selected this architecture to investigate the use of deep
learning methods for breast and FGT segmentation.
The name of the `U-net' stands for the `U'-shape of the network as seen in Fig. 3.1.
This is a fully convolutional network, which consists of convolution and max-pooling
layers at the descending, or in other words, the initial part of the U. This part can be
seen as down-sampling stage, since at each max-pooling layer the input image size is
divided by the size of the max-pooling kernel size. At the later part of the network, or
at the ascending part of the U, up-sampling operations are performed which are also
implemented by convolutions, where kernel weights are learned during training. The
arrows between the 2 parts of the U show the incorporation of the information available
at the down-sampling steps into the up-sampling operations done in the ascending part
of the network. In this way, the ne-detail information captured in descending part of
the network is used at the ascending part.
In this study, we used 4 down-sampling and 4 up-sampling steps. In each down-
sampling step, we used 2 convolutional layers with a kernel size of 3x3, each followed
by a rectied-linear unit (ReLu) for non-linearity, and nally a max-pooling layer with
2x2 kernel size for down-sampling. We used Glorot-uniform82 initialization for weights
of the network and RMSProp83 for gradient-descent optimization. In the up-sampling
steps, we up-convolved the output of the previous step, by initially upscaling the image
by a factor of two using nearest neighbor interpolation, then convolving it with a convo-
lutional layer with a kernel size of 2x2 and a ReLu layer. Then, this was concatenated
with the output of the corresponding down-sampling layer. Finally, 2 convolutional
layers, each followed by a ReLu, were applied to this concatenated image. After the
up-sampling steps, there is a nal convolutional and a following sigmoid unit, which
produces probability outputs for each class. Dierent than the U-net described by
Ronneberger et al.81, we used padded convolutions in this network, which allowed us
to process the whole image at once.
3.2.5 Segmenting Breast and FGT with U-net
The nal goal of the segmentation task in this study is to get 3 class labels within a given
MRI: non-breast (Lnb), fat tissue inside breast (Lfat) and FGT inside breast (LFGT ).
The combination of fat and FGT voxels constitutes the whole breast (Lbreast = Lfat [
LFGT ). Traditional approaches usually perform this segmentation task in 2 steps, rst
segmenting the breast, and at the second step, segmenting FGT within the obtained
breast mask. It would be possible to follow a similar approach by using 2 consecutive
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Figure 3.1: Deep learning network with U-net architecture used in this study. K is the number of
classes.
(2C) U-nets, performing separate but consecutive tasks. On the other hand, it is also
possible to approach the problem as a 3-class (3C) problem and train a single U-net with
3 class-outputs. In this study we investigated both approaches, which are illustrated in
Fig. 3.2. In both approaches, we used all 2-dimensional axial slices as samples provided
to the network in random order. Since we apply 4 max-pooling layers in total, the sizes
of the input images need to be factors of 16 at both dimensions. Therefore, we padded
the images with zero values to meet this criteria before feeding them into the network
and we cropped the output of the network back to the original size of the images. The
nal segmentation was determined by selecting the class for each voxel having highest
corresponding probability, and selecting the largest connected component within the
resulting breast masks. Finally, we combined the output segmentations for all slices of
right and left breasts to get the nal segmentation in the whole MRI. We used all axial
slices of the MR volumes, both in training and testing.
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Figure 3.2: Two dierent approaches for applying U-net to breast and FGT segmentation. The upper
gure shows 2C U-nets, where 2 consecutive U-nets are used. The gure below illustrates the other
approach, a single U-net with 3 class outputs. Pnb, Pbreast, Pfat and PFGT denote the probability
values of voxels to belong to non-breast, breast, fat and FGT, respectively.
Two Consecutive U-nets (2C U-nets)
In this approach, we trained a 2-class U-net for breast segmentation and a subsequent
2-class U-net for FGT/fat segmentation within the breast. To get the nal result,
the segmentation output of the FGT segmentation was masked with the segmentation
output of the breast segmentation. While training the second network, the loss function
was computed only in the breast region dened by the automated breast segmentation
which was produced by the rst network. The reason of not using the manual breast
segmentations during this training stage was to make the FGT segmentation network to
learn to exclude non-relevant voxels from FGT segmentation whenever the rst network
over-segments the breast.
Three-Class Single U-net (3C U-net)
In this approach, the output of the last up-sampling layer of the U-net was convolved
by 3 lters, followed by a sigmoid unit, which outputs the probability values of voxels
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to belong to one of the three classes: Pnb for non-breast, Pfat for fat tissue in the breast
and PFGT for FGT tissue in the breast. For the cost function, we computed the mean
of the negative log-likelihood values of the voxels within the whole slice. However, as
FGT/fat separation occurs within breasts and breasts only occupy a small portion of the
whole MRI volumes (between one-third to one-twentieth of MRI volumes, depending
on the eld-of-view of the acquisition and breast shape), the loss caused by breast/non-
breast separation would dominate the loss caused by FGT/fat separation inside breast,
which results in under-training for FGT segmentation. To prevent this, we weighted
the loss computed inside the breast by a factor of 10.
3.2.6 Existing Methods for Breast and FGT Segmentation
We applied two existing breast segmentation methods to our dataset, one of which also
has an FGT segmentation step.
The atlas-based method by Gubern-Merida et al.65 initially applies a bias eld
correction algorithm and normalizes intensity values in order to reduce intra- and inter-
image intensity variability. Second, the breasts are segmented using spatial information
encoded in a multi-probabilistic atlas27 and the sternum as an anatomical landmark.
FGT segmentation is performed on each breast independently: remaining intensity
inhomogeneities are corrected using N4 and subsequently FCM is applied to select
FGT voxels inside the breast60. Finally, a skin fold removal step is applied.
The sheetness-based breast segmentation method by Wang et al.77 uses second-
order derivatives based on the Hessian matrix in order to enhance voxels that are part
of sheet-like structures. Breast-pectoral and breast-air surfaces are identied using this
information and the breast mask is obtained as a combination of both. This method
does not include an FGT segmentation step.
3.2.7 Experiments and Evaluation
We used 3-fold cross-validation to train and test the U-net methods. We had breast
MRI's from 66 patients, which corresponded to MRI volumes of 132 breasts in total.
Each breast volume consisted of 160 to 260 axial slices in MRI, depending on the ac-
quisition protocol. The separation of the dataset into folds was random, however, we
made sure to keep a balanced distribution of breasts from dierent density categories
in training and test sets. We also took care that both breasts of the same patient were
always placed in the same set. In each fold, MRI's of 5 patients in the training set,
therefore 10 breasts, were excluded from the training set to be used as a validation set.
Therefore we had 39, 5 and 22 MRI scans in training, validation and test sets, respec-
tively, in each fold. Performances on the validation sets during training were measured
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using DSC values. When the performance did not improve any further, the training
was stopped, and the network that corresponds to the highest performance value in
the validation set was selected as the nal network for the fold. This nal network was
applied to the test set. Furthermore, since networks with the U-net architecture are
claimed to be trainable with fewer number of images compared to other deep-learning
algorithms81, we investigated this using the proposed pipeline. Following the same
cross-validation strategy as in the previous experiment, we trained the 3C U-net with
5, 10 and 20 training volumes of each fold. We plotted the resulting DSC values for
breast and FGT segmentations.
We used DSC to measure the overlap between automated and manual segmenta-
tions of the whole MRI volumes. To compare performances of dierent segmentation
algorithms, we applied paired t-test to the DSC values obtained for each MRI. We ap-
plied multiple test correction to the p-values by using Bonferroni correction for 9 tests
(6 tests for the 4 methods in breast segmentation, and 3 tests for the 3 methods in
FGT segmentation). We also reported DSC results per density category, for the cases
where breast density scores as determined by Volpara on a mammogram were available,
as well as DSC results for each MRI protocol used in the acquisitions. Furthermore,
to complement DSC values on the whole dataset, 5 additional performance metrics
were also computed: average Hausdor distance84 (H), average of the highest 5% of H,
maximum H, sensitivity and specicity.
As one of the relevant clinical applications of breast and FGT segmentation is to
provide volumetric breast density, dened as ratio of FGT volume to the breast vol-
ume, we also measured performance of the FGT segmentation methods in this respect.
Pearson's correlation of the volumetric breast density estimates obtained from man-
ual segmentations to the ones obtained from automated segmentations were computed.
The correlation values were compared using Steiger's Z-test for two dependent correla-
tions with one variable in common85,86, with Bonferroni correction for 3 tests. We also
conducted a Bland-Altman analysis in order to investigate any bias in breast density
measurements and how dierences between measurements are distributed. We provided
the plots for the Bland-Altman analysis and we computed limits of agreement (LOA),
coecient of variation (CV, standard deviation of the mean values) and sum of squared
errors (SSE) for each automated segmentation method.
3.3 Results
3.3.1 DSC Values for Breast Segmentation and FGT Segmentation
DSC values of breast and FGT segmentations for each method with respect to the
manual segmentations are given in Table 3.2 and Table 3.3, respectively. DSC values
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Table 3.2: DSC Values for Breast Segmentation: Overall, per Breast Density Category (Ct.) and per
MRI Acquisition Protocol (Pr.)
2C U-nets 3C U-net Atlas-based Sheetness-based
All images (66) 0.944 (0.026) 0.933 (0.028) 0.863 (0.087) 0.848 (0.071)
Density
Ct. 1 (10) 0.953 (0.012) 0.946 (0.018) 0.881 (0.045) 0.874 (0.016)
Ct. 2 (14) 0.937 (0.017) 0.948 (0.012) 0.889 (0.033) 0.870 (0.027)
Ct. 3 (14) 0.938 (0.029) 0.937 (0.019) 0.873 (0.073) 0.858 (0.117)
Ct. 4 (15) 0.906 (0.039) 0.921 (0.03) 0.782 (0.134) 0.775 (0.116)
Protocol
Pr. 1 (27) 0.949 (0.024) 0.939 (0.029) 0.88 (0.06) 0.849 (0.084)
Pr. 2 (17) 0.930 (0.029) 0.928 (0.026) 0.812 (0.13) 0.826 (0.074)
Pr. 3 (4) 0.947 (0.011) 0.936 (0.022) 0.863 (0.036) 0.850 (0.03)
Pr. 4 (13) 0.937 (0.021) 0.926 (0.033) 0.89 (0.035) 0.864 (0.054)
Pr. 5 (5) 0.940 (0.008) 0.938 (0.013) 0.874 (0.04) 0.878 (0.02)
obtained for dierent breast density categories and dierent MRI protocols are also
provided in the same tables. Comparing overall results of the 2 dierent U-net methods,
we see that 2C U-nets performed better by 1.1% in breast segmentation compared to
3C U-net (p=0.0055). On the other hand, 3C U-net achieved a higher DSC value in
FGT segmentation (p<0.0001). Atlas-based and sheetness-based methods performed
signicantly worse compared to U-net methods (p<0.0001 in all comparisons). The
dierence between DSC values of atlas-based and sheetness-based methods was not
statistically signicant (p>0.1).
Regarding the MRI acquisition protocols, the most remarkable drop in segmentation
performance was observed in breast segmentation with atlas-based method for Protocol
2 (Table 3.2). The average DSC for the MRI volumes obtained with this acquisition
protocol was 0.812 (0.13), while it was 0.88 (0.05) for all other MRI volumes obtained
with other acquisition protocols. The comparison between the two averages produced
a p-value of 0.061 when a t-test for independent samples was applied.
To train the second U-net of the 2C U-nets approach, we used automated breast
masks generated from the rst U-net and a DSC value of 0.811 (0.11) for FGT seg-
mentation was obtained. This approach was chosen over using manual breast masks
during training in order to mimic the testing conditions. However, we did not observe
a signicant dierence compared to using manual breast segmentations during training
(DSC of 0.808 (0.16), p=0.73 with paired t-test).
Additional performance measures for breast and FGT segmentations are given in
Table 3.4. The dierences between performances of the methods measured with these
metrics are comparable to the dierences based on DSC measurements. Sensitivity is
an exception to this. Especially sensitivity of the atlas-based method for FGT seg-
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Table 3.3: DSC Values for FGT Segmentation: Overall, per Breast Density Category (Ct.) and per
MRI Acquisition Protocol (Pr.)
2C U-nets 3C U-net Atlas-based
All images (66) 0.811 (0.11) 0.850 (0.086) 0.671 (0.207)
Density
Ct. 1 (10) 0.665 (0.172) 0.748 (0.117) 0.386 (0.140)
Ct. 2 (14) 0.785 (0.09) 0.825 (0.073) 0.659 (0.129)
Ct. 3 (14) 0.877 (0.044) 0.90 (0.038) 0.792 (0.125)
Ct. 4 (15) 0.849 (0.073) 0.870 (0.061) 0.724 (0.185)
Protocol
Pr. 1 (27) 0.792 (0.137) 0.845 (0.1) 0.676 (0.19)
Pr. 2 (17) 0.823 (0.124) 0.857 (0.088) 0.683 (0.202)
Pr. 3 (4) 0.795 (0.086) 0.83 (0.076) 0.625 (0.265)
Pr. 4 (13) 0.835 (0.074) 0.86 (0.067) 0.689 (0.218)
Pr. 5 (5) 0.823 (0.06) 0.843 (0.073) 0.58 (0.302)
Figure 3.3: DSC values obtained when 3C U-net was trained with varying number of volumes in each
fold.
mentation is signicantly higher than those obtained using U-net methods (p < 0.001
with paired t-test for both U-net methods). However, atlas-based method also had a
signicantly lower specicity compared to the same methods (p < 0.001 with paired
t-test for both U-net methods). While the dierence in specicity values might look
small, one should note that FGT regions occupy a small volume pulling the specicity
values close to 1. For the same reason, small dierences in FGT segmentation have a
large eect on sensitivity values.
The changes in segmentation performances of the 3C U-net when trained with 5, 10,
20 and 39 volumes of each fold are illustrated in Fig. 3.3. The DSC values obtained using
20 and 39 training volumes were almost identical for breast segmentation (only 0.002
higher with 39 training volumes and p=0.49 with paired t-test). For the same numbers
of training volumes, the dierence between DSC values obtained for FGT segmentation
was 0.023, which was statistically signicant (p=0.002 with paired t-test).
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Table 3.4: Additional Performance Metrics for Breast and FGT Segmentation
2C U-nets 3C U-net Atlas-based Sheetness-based
Breast
Mean H (mm) 2.9 (1.1) 2.9 (0.1) 5.7 (3.3) 6.0 (2.1)
5% H (mm) 11.2 (4.9) 11.3 (5.2) 21.5 (8.7) 23.7 (9.7)
Max H (mm) 34.3 (15.1) 30.5 (9.2) 40.0 (12.6) 49.2 (15.3)
Sensitivity (%) 93.7 (3.7) 97.6 (2.0) 91.6 (7.5) 93.6 (8.7)
Specicity (%) 99 (0.5) 98.1 (1.0) 96.1 (3.7) 95.0 (3.4)
FGT
Mean H (mm) 3.1 (1.8) 2.6 (0.1) 7.4 (4.6) -
5% H (mm) 11.6 (7.8) 9.7 (5.2) 26.7 (12.4) -
Max H (mm) 49.3 (15.0) 45.0 (9.2) 51.3 (14.3) -
Sensitivity (%) 79.5 (15.2) 84.0 (12.7) 94.0 (9.7) -
Specicity (%) 98.8 (1.3) 99.0 (1.2) 96.8 (2.1) -
3.3.2 Visual Examples
In this section we provide examples from our segmentation results. Fig. 3.4 shows a
case for which segmentation was performed properly by all methods. Other examples
demonstrate how dierent variations and artifacts in MRI volumes may aect segmen-
tation algorithms.
The example given in Fig. 3.5 corresponds to a dense breast (density category 4) in
which the breast-pectoral muscle boundary is less visible due to the presence of dense
tissue.
Fig. 3.6 shows an example of how segmentation algorithms were aected by magnetic
eld inhomogeneities. The strong bias eld visible in the image caused the sheetness-
based method to misinterpret the breast-pectoral muscle boundary at the right breast.
Regarding the atlas-based segmentation approach, although breast segmentation was
not aected by bias-eld, most of the fat voxels were wrongly classied as FGT because
of the same artifact.
In the example shown in Fig. 3.7, ghosting artifacts severely aected atlas-based
segmentation. Additionally, unusual breast and body shape aected both atlas-based
and sheetness-based methods by making them cut the breast boundary at a higher level
than desired. U-net based methods were not aected by ghosting artifacts and breast-
body boundaries were aected minimally. In the other example given in Fig. 3.8, the
shape of the breast was usual compared to the previous case, but strong ghosting eects
still caused problems in both atlas-based and sheetness-based methods for segmenting
the breast.
In most of the cases the image quality is low in caudal and cranial ends of the MRI
volume, which causes diculties for segmentation algorithms. This is demonstrated
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Figure 3.4: A breast MRI, which was segmented accurately by all automated methods.
Figure 3.5: Segmentation for a dense breast (category 4).
in the example given in Fig. 3.9, where U-net based methods showed relatively more
robust performance compared to atlas-based and sheetness-based methods.
Fig. 3.10 illustrates an example where skin folds are present. Not only U-net based
methods, but also atlas-based method was able to exclude skin-folds in this example.
This example also shows an MRI artifact known as "zebra" or "Moire" artifact87, which
had a slight eect on the atlas-based method by making darker pixels classied as FGT
(see area pointed by white arrow in Fig. 3.10).
3.3.3 Measurement of Breast Density
Correlation of the breast density values obtained from manual segmentations to the
values obtained from 2C U-nets, 3C U-net and atlas-based methods were 0.957, 0.974
and 0.938, respectively. In this metric, 3C U-net method had a signicantly better
performance compared to 2C U-nets and atlas-based methods (p<0.0001 and p=0.0016,
respectively). The dierence between the correlation values obtained from atlas-based
and 2C U-nets methods was not statistically signicant (p>0.1). Bland-Altman plots
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Figure 3.6: An example to illustrate the eect of a bias eld on segmentation.
Figure 3.7: An example to illustrate the eect of ghosting artifact on segmentation.
Figure 3.8: An example to illustrate the eect of ghosting artifact on segmentation.
in Fig. 3.11 show that there was a positive bias of 3.8 % in breast density measurements
obtained from the atlas-based method. The bias in 2C U-nets and 3C U-net methods
were -0.8 % and -1.5 %, respectively. According to the same plots, the values for LOA
were smallest in 3C U-net method (5.88) and largest in atlas-based method (7.84).
Both of the U-net methods strongly disagreed with manual segmentation in one
case (indicated by red arrows in Fig.3.11) in breast density measurement. Manual
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Figure 3.9: An example to illustrate the eect of low image quality at the ends of the MRI volume.
Figure 3.10: An example where skin folds of the breast and zebra artifacts are present in the image.
Figure 3.11: Bland-Altman plots for breast density values obtained from automated segmentations
with respect to the values obtained from manual segmentations. Solid lines show the average values
of the dierences in breast density measurements. Dashed lines show the values at a distance of 1.96
times the standard deviation to the mean value. Red arrows point the case with the most disagreement
between estimations using manual and U-net segmentations. This case is shown in Fig. 12.
segmentation resulted in a density value of 42%, while the values obtained from 2C
U-nets and 3C U-net methods were 22% and 23%, respectively. An example slice from
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Figure 3.12: A slice from the MRI for which the strongest disagreement occurred between the density
values obtained from U-net segmentations and manual segmentation.
this case is provided in Fig. 3.12.
3.4 Discussion
In this study we investigated the use of deep learning methods, in particular U-net, for
breast and FGT segmentation. We explored 2 dierent approaches. The rst method
does breast and FGT segmentation in 2 consecutive steps by using 2 U-nets (2C U-nets).
The second method performs this simultaneously in a 3-class U-net (3C U-net). We
collected a challenging dataset that covers a large time-period including variations in
MRI acquisition protocol, in addition to variations in breast density. The two presented
deep learning based methods were applied to this dataset as well as two other previously
published algorithms for comparison.
One of the relevant clinical applications of breast and FGT segmentation is to com-
pute breast density. Our results show that 3-class U-net performed signicantly better
than 2-stages U-nets method and atlas-based method in determining breast density, by
achieving a correlation value of 0.974 with respect to the density values obtained by
manual segmentations. Bland-Altman analysis showed that the LOA was largest for the
atlas-based method, which means that the average dierence between the density values
obtained from manual and atlas-based segmentations tended to be larger than when
computed with the other methods. This nding is in accordance with the correlation
values computed. According to the same analysis, atlas-based method had a tendency
to over-estimate breast density, while a slight tendency in the opposite direction was
observed in U-net based methods. This eect was the strongest in the case shown in
Fig. 3.12. It can be seen that FGT was under-segmented by U-net based methods in
this case. Additionally, breast region was also dened as larger by the U-net methods
compared to the manual segmentation. These together led to the least accurate breast
density estimation with U-net in our dataset.
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According to the DSC values we obtained, U-net based methods outperformed both
of the existing methods by a large margin as given in Table 3.2 and Table 3.3. This
holds for all breast density categories as given in the same tables. In the examples
given in section 3.3.2 we demonstrated how dierent variations in breast images caused
problems for traditional segmentation techniques, while U-net based methods were rel-
atively more stable against these variations. U-net based methods were less aected by
the obscured pectoral muscle boundaries in dense breasts, compared to the traditional
approaches, which is also reected in DSC values. U-net methods were also minimally
aected by MRI artifacts like ghosting eects, while these artifacts troubled both atlas-
based and sheetness-based segmentation methods. Another important observation is
that U-net based methods were minimally aected by intensity inhomogeneities, al-
though no bias-eld correction was applied as a prior step. This indicates that U-net
was able to learn the bias eld in our dataset. According to our observations in the
segmentation results, U-net based methods were relatively more robust to low image
quality, which often occurs at caudal and cranial ends of an MRI volume. Furthermore,
U-net approaches were also capable of learning to exclude skin-folds from the segmen-
tations they output. Another advantage of using U-net over traditional approaches was
regarding the denition of the extent of the breast. Traditional approaches determine
breast area using a distance criteria to anatomical landmarks, such as the sternum,
cutting the resulting segmentation at certain locations. However, as seen in examples
given in Fig. 3.7 and 3.5, this does not generalize well to all breasts. We observed that
U-net based methods had the exibility to learn to mimic the human annotator using
the training examples.
We observed that the performances of U-net and sheetness-based algorithms were
relatively stable across dierent MRI acquisition protocols, while the most remarkable
dierence occurred when the atlas-based method was used for breast segmentation with
MRI scans obtained from the Protocol 2. The DSC value in this set was 0.812, while it
was 0.88 for other MRI protocols. This might be related to the strong ghosting artifacts,
since both of the examples given in Figures 3.7 and 3.8 are images obtained with this
protocol and we have not observed a similar case with the other protocols. However,
the dierence between the DSC values in this set and the DSC values obtained from
other MRI protocols did not reach statistical signicance level (p=0.061). Therefore,
further studies are needed to reach a nal conclusion on how dierent MRI protocols
and systems aect such segmentation algorithms.
Comparing the two U-net based methods, we found that 2C U-nets method per-
formed better in breast segmentation by 1.1% in DSC values. This result may be
expected, as in the former approach the whole network is dedicated to the breast seg-
mentation task, while in the latter approach the same network is performing 2 tasks
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simultaneously. However, the performance of the 3C U-net was better in FGT seg-
mentation. The poorer performance of the 2-stages approach in FGT segmentation
might be related to the propagation of the errors of the breast segmentation stage to
the FGT segmentation stage. Although breast segmentations obtained from 2-stages
approach are slightly better than those obtained from the 3-class network, when an
under-segmentation occurs in this rst stage, there is no way to recover this error in
the second stage because the nal result is masked by the result of breast segmenta-
tion. Such under-segmentation errors directly cause FGT to be under-segmented as
well. There is no such error-propagation problem in 3-class network, since breast seg-
mentation and FGT segmentation is learned and applied simultaneously by the same
network in this approach. This is also reected, as explained above, in the superior
performance of 3C U-net in determining breast density.
We used 39 training volumes in each cross-validation fold. However, we observed
that breast segmentation did not improve any further when we increased the number
of training volumes from 20 to 39. On the other hand, a signicant DSC increase was
observed when the number of volumes used for training was incremented from 20 to
39. This result might be related to the fact that FGT segmentation is more vulnerable
to a variety of MRI artifacts, thus it beneted more from increasing the number of
examples.
Most of the U-net parameters used in this study are based on the parameter values
reported by Ronneberger et al.81. However, we have introduced some modications such
as padded convolutions and the weighting factor in the loss function of the 3C U-net,
which was empirically determined. Furthermore, in this study, rather than splitting the
study dataset into single training, validation and tests sets, we followed a 3-fold cross-
validation strategy to evaluate the presented methods. Following this approach, we were
able to report the performance of the studied algorithms for the whole study dataset. We
observed that a common training procedure with equal hyperparameters, in particular
the learning rate, did not always lead to the most optimal solution. Therefore, we tuned
the learning rate for each fold based on the changes in performance on the corresponding
validation set. The nal networks were selected based on performance on the validation
sets and nally applied to the `unseen' data (i.e. test sets). Hyperparameter tuning is
a known problem and research topic that is currently being investigated88{90.
Our study had some limitations. Although we used MRI scans obtained by dierent
MRI protocols in this study, all scans were obtained in MRI units of Siemens, in the
same hospital, and all of them were non-fat-suppressed images. In the future, we
aim at applying and evaluating the presented methods on a multi-center and multi-
vendor dataset. Furthermore, we did not investigate how inter-reader dierences aect
manual segmentations. Training deep convolutional networks (such as U-nets) require
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a decent amount of data, but preparing manual breast segmentation for a case is a
tedious and time-consuming task. Note that the full process for manually segmenting
breast and FGT may take more than 45 minutes per MRI volume. For the sake of
being able to generate a large dataset, we used single annotation per case in this study,
therefore we were not able to investigate inter-reader variability. Lastly, although we
are dealing with volumetric data, we used a 2-dimensional approach. To improve the
algorithms, in the future we will explore the use of 3D convolutions. We expect this
to be benecial especially for the breast segmentation task in which depth information
might be important.
In conclusion, we investigated using deep learning methods for breast and FGT
segmentation in a challenging dataset that includes many variations in terms of MRI
acquisition and breast density. We based our methods on U-net architecture and we
compared them to two of the existing methods in terms of their segmentation per-
formances. U-net based deep learning methods outperformed two of the traditional
methods in our dataset in both tasks: breast segmentation and breast density compu-
tation.
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Abstract
The amount of broglandular tissue (FGT) is known to be associated with an increased
breast cancer risk. In recent case-control studies background parenchymal enhancement
(BPE) on breast MRI was also proposed as a feature correlating to the development
of breast cancer. In this study the predictive value of FGT and BPE for breast cancer
development and risk of false positive ndings, as measured at baseline, is investigated
in women at increased risk for breast cancer.
Methods: Negative baseline MRI scans of 1533 women participating in a screen-
ing program for women at increased risk for breast cancer between 01/01/2003 and
01/01/2014 were selected. Automated tools based on deep-learning were used to obtain
quantitative measures of FGT and BPE. Logistic regression using forward selection was
used to assess relationships between FGT, BPE, cancer detection, false positive recall
and false positive biopsy.
Results: Sixty cancers were detected in follow-up. FGT and BPE were not associated
with breast cancer risk (p=0.540 and p=0.112, respectively). High FGT and BPE
did lead to more false positive recalls at baseline (OR:1.259, p=0.050 and OR:1.475,
p=0.003) and to more frequent false positive biopsies at baseline (OR:1.315, p=0.049
and OR:1.807, p=0.002), but were not predictive for false positive ndings in subsequent
screening rounds.
Conclusion: FGT and BPE, measured on baseline MRI, are not predictive for breast
cancer development in women at increased risk. High FGT and BPE lead to more false
positive ndings at baseline.
Impact: FGT and BPE cannot be implemented in risk prediction models.
4.1 Introduction 61
4.1 Introduction
Women at increased risk of breast cancer (>20-25% life time risk) are eligible for in-
tensied screening programs, including a yearly breast Magnetic Resonance Imaging
(MRI) study. Depending on the underlying risk factors, MRIs may be performed on
an annual basis from the age of 25 (in BRCA mutation carriers)91,92. Women with a
hereditary germline mutation and women with a history of radiation therapy to the
chest at young age are eligible to these programs. For other women, risk prediction
tools are used to determine whether women are at increased risk and thus eligible for
MRI screening. The current risk prediction tools rely mainly on personal factors, such
as family history, age, race, etc.93,94. However, recent studies show that additional
independent risk factors, including imaging biomarkers, might increase the predictive
power of risk prediction.
Mammographic breast density (BD), for example, correlates to breast cancer risk
in the general female population and in BRCA mutation carriers95,96. Consequently, a
number of studies recommend adding BD to the available risk prediction tools97{100.
The increased use of breast MRI allows for evaluation of additional risk factors to
improve current risk prediction tools. Recent publications indicate that the amount
of broglandular tissue (FGT) and/ or background parenchymal enhancement (BPE)
measured on breast MRI may be useful to predict breast cancer risk in women under-
going breast MRI101{103.
While in breast MRI all normal FGT enhances after contrast injection, the strength
and speed of enhancement is dependent on variations in hormone levels, as determined
by menstrual cycle phase, menopausal status, tamoxifen therapy, and hormone replace-
ment therapy104{106. Studies of King et al. and Dontchos et al.101,102 showed that
higher amounts of BPE in the contralateral breast increase the risk of a breast cancer
diagnosis. Their results thus suggest that BPE might be used for the prediction of
breast cancer risk. Unfortunately, both studies evaluated BPE at time of breast cancer
detection, and are therefore unable to document its predictive value for future breast
cancer occurrence.
A further problem is that visual rating of BPE on a four point scale (minimal
<25%, mild 25-50%, moderate 50-75%, and marked 75-100%), as used in the studies so
far, suers from high interrater variability107. This limits its value for risk prediction.
Analogue to the systems currently in use to automatically estimate BD on digital mam-
mograms, automated tools to assess FGT and BPE may reduce interrater variability
and possibly provide more robust parameters for risk stratication.
The purpose of the current study is therefore to study whether FGT and BPE as
computed on a cancer free baseline MRI-scan using an automated tool, are predictors of
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future breast cancer in an intermediate and high-risk breast cancer screening program.
Furthermore, we evaluate whether FGT and BPE predict false positive ndings.
4.2 Materials and Methods
This retrospective cohort study was approved by our local institutional review board
and the requirement for informed consent was waived.
4.2.1 Screening program
The breast cancer screening program for women with a lifetime risk of >20-25% at our
institution consists of annual breast MRI and mammography91,108. In BRCA mutation
carriers, the screening regimen starts with breast MRI only at the age of 25. Mam-
mography is added from age 30. Others start screening with both modalities at age 35
or 40, depending on the age at which relatives developed breast cancer. The rst MRI
scan performed for screening is hereafter referred to as the `baseline' MRI.
4.2.2 Case selection
The local database was searched to identify all patients who underwent breast MRI
screening between 01/01/2003-01/01/2014. The case selection process is presented
in Figure 4.1. Women of any age were included when they underwent at least two
breast MRI examinations for screening in this period. We recorded for each patient
whether a BRCAmutation was present and whether and when a risk reducing salphingo-
oophorectomy (RRSO) was performed. Women in whom a cancer was detected at the
baseline MRI or within 6 months thereafter, women with a prior history of breast cancer,
and women in whom the automated assessment of BPE failed were excluded. We did
not exclude women who had a false positive nding in the rst round of screening.
4.2.3 Ground truth
Normal or benign screening examinations were conrmed by at least one year of clinical
follow up and regarded as true negative when no cancer was detected before the subse-
quent screening examination. When no biopsy was indicated at short-term follow-up,
at least one year of clinical follow up was required to conrm benignity. Biopsied lesions
were identied by a cross-computer search with our pathology records. We subsequently
analyzed if the biopsy was performed based on screening ndings or for other reasons
(e.g. symptoms).
4.2 Materials and Methods 63
4.2.4 Image acquisition
MRI Protocols varied over time109. Dynamic contrast enhanced breast MRI acquisitions
were performed on either a 1.5 or 3 Tesla Siemens scanner using a dedicated bilateral
breast coil. Patients were placed in prone position. A transverse or coronal three-
dimensional T1-weighted gradient-echo (GRE) dynamic sequence was performed before
contrast agent administration followed by 4 or 5 post-contrast sequences. The rst time
point was acquired before intravenous agent injection and the following time points after
injection of the contrast agent. The gadolinium chelates were administered at a dose
of 0.1 mmol/kg or 0.2 mmol/kg using a power injector (Medrad, Warrendale, PA),
followed by a saline ush.
4.2.5 Imaging interpretation
Automatic tools were used to objectively calculate percentages of FGT and BPE on
breast MRI volumes. Breast and FGT were segmented on the native T1-weighted
pre-contrast acquisitions using a deep-learning based method as described in109. The
fraction of FGT was calculated as the segmented volume of FGT divided by the total
breast volume. BPE relative enhancement values were computed using the pre-contrast
and the rst post-contrast T1-weighted acquisition after motion correction27, according
to the ACR guidelines110,111. The fraction of BPE is expressed relative to the volume of
the FGT, where an FGT voxel is considered to enhance if it has a relative enhancement
value higher than 10%. According to Dalmis et al.60, who correlated BPE as scored
by the automated tool to BPE as rated by radiologists, 10% relative enhancement
correlates best. Figure 4.2 shows an example of automated computations of FGT
and BPE. Final FGT and BPE measurements were the result of averaging over the
two breasts of each woman. To verify whether correlations change when investigating
dierent cut-o values, we performed the same analysis on 20%, 30%, 40% and 50%
relative enhancement values (Table 4.5).
4.2.6 Data-analysis
Women who developed cancer were identied by linkage of our data to the Netherlands
Comprehensive Cancer Organisation. False positive MRI examinations were dened
as examinations that led to recall in women in whom no breast cancer was detected.
False positive recalls (FPR) include all women who were recalled (with or without
performance of biopsy). False positive biopsies (FPB) only include the women for
whom the recall led to biopsy. We separated FPR and FPB in the rst round from
those that occurred in subsequent screening rounds.
64 Automatically assessed FGT and BPE in relation to breast cancer risk
4.2.7 Statistical analysis
Incomplete data was assumed to be missing at random and was excluded. Descriptive
statistics were prepared with the use of contingency-table analysis for categorical data
and Fishers exact tests. The 95% condence intervals (95% CI) for proportions were
estimated using the Z-test for single proportions. Continuous data were compared with
the Students t-test or Pearson correlation coecient (r) when normally distributed,
otherwise Mann-Whitney U tests were used. Bootstrapping (N=1000) was used to cal-
culate 95% CI. To increase statistical power, FGT and BPE were dichotomized into
two categories based on the optimal categories in ROC-analysis (0-50th percentile and
50-100th percentile). A binary logistic regression model was constructed to nd inde-
pendent predictors for breast cancer or false positives. Separate and combined models
were performed for FGT and BPE. Inclusion of variables in the model was based on ex-
isting knowledge of risk factors for breast cancer and/or false positives (covariates: age
and BRCA status). Non-linear eects were evaluated using Box-Tidwell tests and when
needed transformations were performed. The value of predictors was assessed by using
forward feature selection (using a liberal probability-to-enter of 0.1). Interactions be-
tween predictors were evaluated in the nal models by including interaction terms along
with the main-eect terms. The nal model was bootstrapped (N=1000). Shrinkage
using the heuristic method was applied to account for over-optimism112. Odds ratios
(OR) were used to report on the relative odds of the occurrence of the outcome (future
cancer, or false positive result), where OR=1 means that the predictor does not aect
odds of outcome; OR>1 means that the predictor is associated with higher odds of out-
come; and OR<1 means that the predictor is associated with lower odds of outcome.
All statistical tests were two-sided. P60.05 was considered signicant. All statistics
were performed in SPSS (version 22, SPSS Inc., Chicago, IL).
4.3 Results
4.3.1 Population
The nal analysis evaluated baseline breast MRI scans of 1533 women, including 573
(37.4%) BRCA mutation carriers (Table 4.3). Patient selection and exclusion is shown
in Figure 4.1. The median age at baseline was 41 years (37 years for BRCA mutation
carriers, and 44 years for others). In 60 (3.9%) women, cancer was identied after a
negative baseline scan. 45 (75%) cancers were screen-detected cancers, 6 (10%) were
interval cancers, and 9 (15%) cancers were detected in prophylactic mastectomies. 43
(71.7%) cancers were invasive and 17 (28.3%) were ductal carcinoma in situ (DCIS)
only. The median time between the negative baseline scan and cancer detection was 3
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years (2 in BRCA patients, 3 in others). Of the 573 BRCA mutation carriers 103 (18%)
women had a RRSO prior to the rst screening round.
337 (22.0%) women had a false positive recall. Seventy-three (21.7%) of these women
were recalled based upon mammography ndings. 264 (78.3%) women had at least one
false positive recall based on the MRI exam (total: 286 recalls on MRI), and 203 (13.2%)
women had at least one false positive biopsy due to MRI ndings (total: 217 biopsies).
Median FGT measured on MRI was 12.7% (IQR: 18.9%), and median BPE was 67.7%
(interquartile range (IQR): 27.6%). A more detailed presentation of the population
characteristics is presented in Tables 4.1a-4.1c.
In univariate analysis, a signicant association between FGT and BRCA status was
found in both percentages (p=0.001) and the dichotomous scores (p<0.001). BRCA
mutation carriers had lower FGT scores than others. Interestingly, the BRCA muta-
tion carriers had a lower age at the baseline scan (Median age of 37 for BRCA muta-
tion carriers versus 44 for others, p<0.001). A similar association was found between
the percentage of BPE and BRCA status (p=0.005), as BRCA mutation carriers had
signicantly lower BPE scores. When dichotomizing BPE, this remained signicant
(p=0.020). FGT and BPE were negatively correlated to age (r=-0.289 and r=-0.129,
p<0.001), also when using dichotomous values (p60.007). In BRCA mutation carri-
ers coecients were r=-0.418 (p<0.001) and r=-0.132 (p=0.002), respectively, and in
women without a BRCA mutation r=-0.307 (p<0.001) and r=-0.152 (p<0.001). FGT
and BPE were not correlated (p=0.879). Plots of the univariate analysis are presented
in Fig. 4.3-4.4. In BRCA mutation carriers, BPE was not associated with a history of
RRSO (p=0.886, Table 4.1b).
4.3.2 Cancer prediction models
In univariate analysis, FGT was not associated with breast cancer for both discrete
(p=0.768) and dichotomous values (p=0.511). In regression analysis, FGT was not
considered an independent risk factor for breast cancer, only BRCA status was (OR:
3.615, p=0.001). Likewise, percentages and dichotomized BPE scores of the baseline
MRI scan were not associated with breast cancer (p=0.625 and p=0.236, respectively).
In regression analysis, adjusting for the only signicant risk factor (BRCA status),
BPE was also no signicant predictor of cancer (p=0.112). When evaluating both FGT
and BPE, both were not signicantly associated with breast cancer risk (p=0.824 and
p=0.112). Also in the subgroup of the BRCA and non-BRCA mutation carriers only,
BPE and FGT were not associated to breast cancer. Details of predictors can be found
in Table 4.2a.
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4.3.3 False positive recall (FPR) models
When investigating the rst round results alone (diagnostic model), both FGT and BPE
were correlated to higher FPR rates (OR: 1.259; p=0.050, and OR: 1.475; p=0.003,
respectively). For subsequent rounds (prognostic model), higher FGT at baseline was
still signicantly related to higher FPR in both continuous and dichotomized values
(p60.029). BPE, however, was not related to FPR (p>0.818) in univariate analysis. In
regression analysis only age remained as related factor to FPR in follow up (OR: 0.955,
p=0.001, Table 4.2b).
4.3.4 False positive biopsy (FPB) models
When only investigating the rst round (diagnostic model), both FGT and BPE were
correlated to higher FPB (OR: 1.315 (p=0.049) and OR: 1.807 (p=0.002), respec-
tively).When excluding the FPB in the rst round (prognostic model), FGT and BPE
were both not related to false positive biopsies (p>0.066) in univariate analysis. Re-
gression analysis showed that age was negatively related to FPB in follow up (p=0.001,
Table 4.2b).
No interaction terms were found to be signicant in none of the prediction models.
In addition, changing levels of BPE cut-os did not change any of the conclusions for
both the cancer- and false positive prediction models (Table 4.4 and 4.5).
4.4 Discussion
The purpose of this study was to investigate the predictive value of FGT and BPE
in predicting breast cancer risk in a population at increased risk of developing breast
cancer. Additionally, the eect of FGT and BPE on false positive recalls and biopsies
was investigated. Our results show that neither FGT nor BPE at baseline was associated
with the risk of developing breast cancer. Both higher FGT and BPE did lead to higher
odds ratios for false positive ndings in the baseline examination. We did not observe
any predictive value of FGT or BPE for FPR or FPB in subsequent screening rounds.
It has already been well established that mammographic BD impairs mammographic
sensitivity113. In an average risk population, BD is also known to correlate with breast
cancer risk95. In line with the studies from Dontchos et al.101 and Passaperuma et al.114
who reported that neither mammographic BD nor FGT on MR images was predictive
of breast cancer risk in women at increased risk, we did not observe a correlation
between the fraction of FGT and the development of breast cancer in our high risk
cohort. However, Mitchell et al.96 reported contradictory results. In their study it was
suggested that high BD in BRCA mutation carriers increased the risk of breast cancer,
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with a relative risk similar to that observed in the general population. The discordance
between this report and our ndings may at least partly be explained by the automated
volumetric FGT estimation in our study, which provides a dierent representation of
the FGT than visually inspected BD in mammography, albeit previous studies showed
a clear correlation between these measurements115. It may also be related to the limited
sample size in our study and other studies published thus far.
Current clinical practice is shifting towards personalized screening, making risk pre-
diction tools increasingly important. Recent case-control studies have shown that BPE
might be predictive of breast cancer risk101,102, although contradictory results exist for
non-high risk women116. However, in these studies the BPE scores of the healthy breast
(partly for101) in breast cancer patients were compared to BPE scores in healthy con-
trols. The current study, in which the BPE before cancer development is evaluated
in actual patients, suggests that BPE is not predictive for breast cancer in women at
increased risk. A possible explanation for this is that in case-control studies BPE in can-
cer patients might have been aected by the presence of breast cancer. Consequently,
further research into the biological basis and modifying factors of BPE is needed. Al-
ternatively, our results might point to a dierent carcinogenesis in women at increased
risk.
Evidence suggests that BPE correlates negatively with age and increases with hor-
monal activity117{119. Interestingly, our results showed that BRCA mutation carriers
had signicantly lower FGT and BPE values compared to women without a BRCA
mutation, while the age of BRCA mutation carriers was signicantly lower than that of
women without BRCA mutation. This counterintuitive result may be due to dierences
in the eect of hormones on FGT in women with and without BRCA mutation120. The
fact that we did not observe a dierence in BPE between the BRCA mutation carriers
who did and did-not undergo a RRSO before the baseline MRI (p=0.886) also points
in this direction. Nevertheless, prior research showed that RRSO may still reduce both
BPE and FGT values121, and therefore our results need to be interpreted with caution
as they might also be explained by the relatively low number of women who underwent
RRSO in our study. It should be noted that the performance of RRSO in BRCA mu-
tation carriers after the baseline examination may have had impact on the predictive
value of FGT and BPE in these women.
Women with high BPE scores had a 1.5 times higher chance to get a FPR, and
1.8 times higher chance to get a FPB in the rst screening round. This is in line with
previous studies, describing that more focal, regional, or asymmetric BPE was asso-
ciated with a higher likelihood of BI-RADS 3 assessment in the screening setting122.
Giess et al. stated that, in the latter case, it may be hard to distinguish BPE from
non-mass enhancement (NME)123. Consequently, when the enhancement pattern is
68 Automatically assessed FGT and BPE in relation to breast cancer risk
interpreted as NME, the reporting radiologist has to consider the possibility of malig-
nancy, thus chances on false positives increase. DeMartini et al.124 also reported that
higher amounts of BPE were associated with higher rates of abnormal interpretation.
Brennan et al. reported that moderate and marked BPE are associated with signi-
cantly higher MR imaging-guided core biopsy cancellation rates compared to minimal
or mild BPE125. However, the even stronger correlation between BPE and FPB in
our study unfortunately suggests that many biopsies are still performed due to BPE.
Nevertheless, neither BPE nor FGT is predictive of false positive recalls or biopsies in
subsequent screening rounds, which could mean that BPE and FGT are only aecting
false positives when no prior exams are available.
The automated algorithm for BPE estimation eliminates intra- and interrater vari-
ability. This is relevant as previous studies reported only a fair interrater variability for
BPE when using observer scores according to the BI-RADS lexicon107. The automated
method provides quantitative measurements and therefore creates an opportunity to
dene more precise cut-o points. The chosen cut-o was selected based upon previous
research, but it is possible that dierent cut-o points might lead to dierent results,
but did not lead to dierent conclusions. This is in line with a recent study on the
prognostic value of BPE in the contralateral breast of women with unilateral breast
cancer, where the eect of dierent cut-os appeared to be minimal126. Nevertheless,
it should be noted that the dierent methods to assess BPE may also lead to dierent
outcomes in the risk model.
Our study has some limitations. Due to the retrospective nature of our data, it
was not always possible to retrieve data on the menstrual cycle or menopausal status.
Therefore, we could not correct for these factors. In addition, this was a single insti-
tutional study, which potentially limits its generalizability. During the study period,
we changed from a 1.5 T scanner to a 3 T scanner, and also adapted the scanning
protocol several times which could potentially inuence the results of the BPE calcu-
lation algorithm. Another possible limitation of the study was that, only in the case
of false positive ndings, we did not exclude women who had a false positive nding
directly after the rst screening round. In theory this could alter FGT and BPE scores,
although we minimized this eect by averaging scores over two breasts.
In conclusion, automatically computed FGT and BPE measures at baseline were not
associated with subsequent breast cancer occurrence in a cohort of women at high risk
for breast cancer. This has implications for personalized screening, as FGT and BPE
cannot be implemented in risk prediction models. Higher FGT and BPE were, however,
associated with higher rates of false positive ndings at baseline, patient counseling
should therefore include these outcomes before starting MRI screening.
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Table 4.1: Baseline characteristics of patients.
N/A: not applicable, BPE: background parenchymal enhancement, FGT: amount of broglandular
tissue, IQR: the dierence between the 75th and 25th percentiles, RRSO: risk-reducing salpingo-
oophorectomy
 fraction: fraction of positive cases
$ Tested on normality using the Kolgomorov-Smirnov test.
(a) Baseline patient characteristics.
Total cohort Developed cancer
(N=1533) Yes (N=60) No (N=1473)
Age in years (median$, IQR) 41 (17.0) 40 (13.0) 42 (17.0)
BRCA mutation carriers (N, fraction*) 573, 0.37 41, 0.68 532, 0.36
FGT in percentage (median$, IQR) 12.7 (18.9) 11.6 (19.8) 12.7 (18.7)
BPE in percentage (median$, IQR) 67.7 (27.6) 71.3 (30.4) 67.6 (27.6)
Cancer (N, ratio*) 60, 0.04 60 (N/A) N/A
- Age at cancer detection (median$, IQR) 42 (15.0) 42 (15.0) N/A
False positive recall overall (N, fraction*) 337, 0.22 19, 0.32 318, 0.22
- Age at recall (median$, IQR) 42 (15.0) 40 (18.0) 42 (15.0)
False positive recall MRI (N, fraction*) 264, 0.17 16, 0.27 248, 0.17
- Age at recall (median$, IQR) 40 (15.0) 39 (16.8) 40 (15.0)
False positive biopsy overall (N, fraction*) 221, 0.14 12, 0.20 209, 0.14
- Age at biopsy (median$, IQR) 41 (14.5) 39 (16.5) 41 (14.5)
False positive biopsy MRI (N, fraction*) 203, 0.13 11, 0.18 192, 0.13
- Age at biopsy (median$, IQR) 40 (15.0) 38 (18.0) 40 (15.0)
RRSO (N, fraction*) 103, 0.18 5, 0.12 98, 0.18
(b) Baseline characteristics of BRCA mutation carriers
Total cohort Developed cancer
(N=573) Yes (N=41) No (N=532)
Age in years (median$, IQR) 37 (17) 41 (14.5) 37 (18)
FGT in percentage (median$, IQR) 9.3 (14.5) 10.7 (16.7) 9.3 (14.5)
BPE in percentage (median$, IQR) 65.6 (26.7) 71.2 (33.3) 65.1 (26.1)
Cancer (N, fraction*) 41, 0.07 41, 1.00 0, 0.00
- Age at cancer detection (median$, IQR) 42 (14.5) 42 (14.5) N/A
False positive recall overall (N, fraction*) 118, 0.21 12, 0.29 106, 0.20
- Age at recall (median$, IQR) 38.5 (15) 38 (19.5) 39 (14.3)
False positive recall MRI (N, fraction*) 97, 0.17 10, 0.24 87, 0.16
- Age at recall (median$, IQR) 38 (14.5) 38 (18.75) 39 (14)
False positive biopsy overall (N, fraction*) 80, 0.14 7, 0.17 73, 0.14
- Age at biopsy (median$, IQR) 38 (14) 34 (11) 39 (14.5)
False positive biopsy MRI (N, fraction*) 72, 0.13 7, 0.17 65, 0.12
- Age at biopsy (median$, IQR) 38 (15.3) 34 (11) 38 (15.5)
RRSO (N, fraction*) 103, 0.18 5, 0.12 98, 0.18
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(c) Baseline characteristics of others at increased risk
Total cohort Developed cancer
(N=960) Yes (N=19) No (N=941)
Age in years (median$, IQR) 44 (15) 40 (11) 44 (15)
FGT in percentage (median$, IQR) 14.9 (20.7) 20.8 (20.5) 14.8 (20.6)
BPE in percentage (median$, IQR) 69.0 (27.6) 73.4 (29.1) 69.0 (27.6)
Cancer (N, fraction*) 19, 0.02 19, 1.00 N/A
- Age at cancer detection (median$, IQR) 43 (16) 40 (11) N/A
False positive recall overall (N, fraction*) 219, 0.23 7, 0.37 212, 0.23
- Age at recall (median$, IQR) 43 (14) 46 (15) 43 (14)
False positive recall MRI (N, fraction*) 167, 0.23 6, 0.32 161, 0.17
- Age at recall (median$, IQR) 42 (15) 47.5 (17.8) 42 (14)
False positive biopsy overall (N, fraction*) 141, 0.15 5, 0.26 136, 0.14
- Age at biopsy (median$, IQR) 43 (14) 46 (10) 43 (14)
False positive biopsy MRI (N, fraction*) 131, 0.14 4, 0.21 127, 0.13
- Age at biopsy (median$, IQR) 42 (14) 47.5 (12.5) 42 (14)
RRSO (N, fraction*) 1, >0.00 0, 0.00 1, >0.00
Table 4.2: Regression coecients and odds ratios.
For every model dierent shrinkage factors were used, shrunk  and OR are presented.
 FGT and BPE = low is reference category
: standardized coecients, OR: odds ratio, CI: condence interval, FGT: amount of broglandular tissue, BPE:
background parenchymal enhancement, SF: shrinkage factor
(a) Regression coecients and odds ratios for the prognostic cancer prediction model
Model Predictor P-value
Included in
nal model

(95% CI)
OR
(95% CI)
Shrinkage
factor
Overall population
Cancer-FGT
BRCA* <0.001 x 1.285 (0.762 1.872) 3.615 (2.143 6.501) 0,96
Age 0,93 -
FGT 0,511 -
Cancer-BPE
BRCA* <0.001 x 1.285 (0.769 1.875) 3.615 (2.158 6.521) 0,96
Age 0,93 -
BPE 0,236 -
Subgroup BRCA
Cancer-FGT
Age 0,33 -
N/A
FGT 0,936 -
Cancer-BPE
Age 0,33 -
N/A
BPE 0,106 -
Subgroup non-BRCA
Cancer-FGT
Age 0,126 -
N/A
FGT 0,621 -
Cancer-BPE
Age 0,126 -
N/A
BPE 0,641 -
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(b) Regression coecients and odds ratios for the eect on current and subsequent MRI scans on false
positive ndings
Model Predictor P-value Included
in nal
model
(95% CI)
OR(95% CI) SF
Diagnostic model for false positive ndings (current MRI scans)
FP Recall-FGT
BRCA 0,771 -
Age 0,167 -
FGT* 0,05 x 0.230 (0.012 0.451) 1.259 (1.012 1.569) 0,74
FP Recall-BPE
BRCA 0,612 -
Age 0,102 -
BPE* 0,003 x 0.389 (0.120 0.666) 1.475 (1.128 1.946) 0,87
FP Recall-FGT and BPE
BRCA 0,894 -
Age 0,229 -
FGT* 0,072 x 0.251 (-0.013 0.535) 1.285 (0.987 1.707) 0,83
BPE* 0,005 x 0.366 (0.111 0.625) 1.442 (1.118 1.868)
FP Biopsy-FGT
BRCA 0,35 -
Age 0,496 -
FGT* 0,049 x 0.274 (0.022 0.568) 1.315 (1.022 1.765) 0,74
FP Biopsy-BPE
BRCA 0,269 -
Age 0,362 -
BPE* 0,002 x 0.592 (0.253 0.957) 1.807 (1.288 2.605) 0,91
FP Biopsy-FGT and BPE
BRCA 0,453 -
Age 0,651 -
FGT* 0,064 x 0.312 (-0.012 0.677) 1.367 (0.988 1.968) 0,87
BPE* 0,002 x 0.559 (0.218 0.911) 1.750 (1.243 2.487)
Prognostic model for false positive ndings
FP Recall-FGT
BRCA 0,773 -
Age 0,001 x -0.047 (-0.069 - -0.026) 0.955 (0.933 0.975) 0,95
FGT 0,224 -
FP Recall-BPE
BRCA 0,773 -
Age 0,001 x -0.047 (-0.069 - -0.026) 0.955 (0.933 0.975) 0,95
BPE 0,932 -
FP Biopsy-FGT
BRCA 0,892 -
Age 0,001 x -0.051 (-0.081 - -0.026) 0.951 (0.922 0.974) 0,94
FGT 0,557 -
FP Biopsy-BPE
BRCA 0,892 -
Age 0,001 x -0.051 (-0.081 - -0.026) 0.951 (0.922 0.974) 0,94
BPE 0,572 -
Table 4.3: Risk factor for breast MRI screening.
Risk factor Number of women (%)
BRCA mutation carriers 573 (37%)
Family history, non-BRCA 642 (42%)
Other reasons for screening 318 (21%)
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Table 4.4: Background parenchymal enhancement (BPE) values for dierent cut-o values of the
deep-learning system. IQR: the dierence between the 75th and 25th percentiles.
Total cohort Developed cancer
(N=1533) Yes (N=60) No (N=1473)
BPE in percentage (median, IQR) (10%) 67.7 (27.6) 71.3 (30.4) 67.6 (27.6)
BPE in percentage (median, IQR) (20%) 50.4 (32.5) 52.6 (38.8) 49.8 (32.0)
BPE in percentage (median, IQR) (30%) 38.0 (32.4) 38.6 (39.7) 35.3 (31.9)
BPE in percentage (median, IQR) (40%) 29.1 (28.4) 26.9 (36.1) 25.6 (28.3)
BPE in percentage (median, IQR) (50%) 22.7 (24.2) 18.8 (30.4) 18.6 (23.9)
Table 4.5: Regression coecients and odds ratios for the dierent BPE cut-os (20%, 30%, 40%, 50%)
for the eect on current and subsequent MRI scans on cancer false positive ndings. For every model
dierent shrinkage factors were used, shrunk  and OR are presented. * FGT and BPE = low is
reference category : standardized coecients, OR: odds ratio, CI: condence interval, FGT: amount
of broglandular tissue, BPE: background parenchymal enhancement, SF: shrinkage factor
Model Predictor P-value Included
in nal
model

(95% CI)
OR(95% CI) SF
Prognostic cancer model
Cancer-BPE 20% - 50%
BRCA 0,771 -
Age 0,167 -
FGT* 0,05 x 1.285 (0.747 1.908) 3.616 (2.110 6.743) 0.96
Current false positive recall model
FPR-BPE 20%
BRCA 0,623 -
Age 0,120 - 0.404 (0.133 0.704) 1.498 (1.142 2.022) 0.88
FGT 0,005 x
FPR-BPE 30%
BRCA 0,605 -
Age 0,144 - -0.009 (-0.018 0.000) 1.461 (1.105 1.944) 0.87
BPE 0,005 x
FPR-BPE 40%
BRCA 0,299 -
Age 0,046 x -0.009 (-0.018 -0.000) 0.991 (0.982 1.000) 0.70
BPE 0,299 -
FPR-BPE 50%
BRCA 0,299 -
Age 0,045 x -0.009 (-0.018 -0.001) 0.991 (0.982 0.999) 0.70
BPE 0,424 -
Prognostic false positive recall model
FP Recall-FGT
BRCA 0,773 -
Age 0,001 x -0.047 (-0.070 0.027) 0.954 (0.932 0.973) 0.95
FGT 0,839 -
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Figure 4.3: Distribution of the amount of broglandular tissue (FGT) for women with a BRCA
mutation and women without a BRCA mutation. In (a), box plots show lowest and highest FGT
values (outermost horizontal lines), median FGT (central horizontal line), and interquartile range (top
and bottom borders of the box) for breast cancer (no/yes). Scatter plots showing association of FGT
to breast cancer occurrence (no/yes) and age at baseline MRI (b). In (c) boxplots are shown for false
positive recall occurrence (no/yes), and in (d) scatterplots show the association of FGT to false positive
recall occurrence.
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Figure 4.4: Distribution of the background parenchymal enhancement (BPE) for women with a BRCA
mutation and women without a BRCA mutation. In (a), box plots show lowest and highest BPE values
(outermost horizontal lines), median BPE (central horizontal line), and interquartile range (top and
bottom borders of the box) for breast cancer (no/yes). Scatter plots showing association of BPE to
breast cancer occurrence (no/yes) and age at baseline MRI (b). In (c) boxplots are shown for false
positive recall occurrence (no/yes), and in (d) scatterplots show the association of BPE to false positive
recall occurrence.
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Abstract
Current computer-aided detection (CADe) systems for contrast-enhanced breast MRI
rely on both spatial information obtained from the early-phase and temporal informa-
tion obtained from the late-phase of the contrast enhancement. However, late-phase
information might not be available in a screening setting, such as in novel abbreviated
MRI protocols, where acquisition is limited to early-phase scans. In this study, we used
deep learning to develop a CADe system that exploits the spatial information obtained
from the early-phase scans. This system uses 3-dimensional morphological information
in the candidate locations and the symmetry information arising from the enhancement
dierences of the two breasts. We compared the proposed system to a previously devel-
oped system which uses the full dynamic breast MRI protocol. For training and testing
we used 385 MRI scans, containing 161 malignant lesions. Performance was measured
by averaging the sensitivity values between 1/8-8 false positives. In our experiments the
proposed system obtained a signicantly (p=0.008) higher average sensitivity (0.6429
0.0537) compared to that of the previous CADe system (0.5325 0.0547). In con-
clusion, we developed a CADe system which is able to exploit the spatial information
obtained from the early-phase scans and can be used in screening programs where
abbreviated MRI protocols are used.
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5.1 Introduction
Breast magnetic resonance imaging (MRI) is known for its high sensitivity in detecting
breast lesions. It has been shown that lesions that are occult in mammography and
ultrasonography can be detected in breast MRI127. In a typical breast MRI acquisition
protocol, after an initial T1-weighted (T1w) MRI scan is obtained, a contrast agent is
administered to the patient to enhance lesions, and, subsequently, several post-contrast
T1wMRI scans are obtained. Lesions become visible in the subtraction volume obtained
from pre- and the rst post-contrast volumes, which are referred to as early-phase
scans. The additional T1w scans obtained after the rst post-contrast MRI are used for
evaluating contrast enhancement dynamics of a lesion in the late-phase, which provides
adjunct information for distinguishing the benign structures from the malignant ones105.
Despite the higher sensitivity of breast MRI, mammography remains as the standard
modality for general screening of women for breast cancer, since high cost of breast MRI
limits its widespread use. One of the cost-increasing factors is the acquisition of several
scans obtained for a single breast MRI study. To decrease the cost and be able to
facilitate the application of this imaging modality in screening, abbreviated breast MRI
protocols have been suggested29,30, where the late-phase T1w acquisitions of the full
DCE-MRI protocol are not obtained in order to reduce the protocol time. In a simple
abbreviated protocol, evaluation of an enhancing structure is based only on morpho-
logical information obtained from the early-phase scans. Additionally, a quick reading
protocol was suggested for the abbreviated protocols, since interpretation of high di-
mensional images is time consuming for radiologists. In this quick reading protocol,
maximum-intensity projection (MIP) images of the rst post-contrast subtraction vol-
umes are used. The radiologist initially decides on the presence of suspicious regions
based on the MIP image. Then, in case of a positive decision, the 3-dimensional (3D)
subtraction volume is also inspected for a nal conclusion. This reading method reduces
the reading time from a reported average of 4.7 minutes128 to less than one minute29,30.
However, this quick reading protocol may increase reading errors. Such reading errors
are not uncommon even when a full diagnostic breast MRI protocol is used. Several
studies129{131 showed that up to 56% of the cancer lesions detected in MRI could have
been detected in earlier MRI scans but they were misinterpreted or overlooked by the
readers. Studies on abbreviated protocols indicate that reading errors may occur more
often when a quick reading protocol is used, as it was found that some lesions were
missed due to the use of MIP images as a rst step in the reading workow29,30.
Computer-aided detection (CADe) systems25{28 have been developed to aid radiolo-
gists reading breast MRI. These systems have the potential to reduce reading time and
prevent reading errors since they are able to detect lesions that were misinterpreted
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or overlooked by radiologists during breast MRI screening132. However, current breast
MRI CADe algorithms rely on the full breast MRI protocol including the temporal
information from the late-phase scans, in addition to the morphological information
obtained from the early-phase scans. This is an important limitation since it limits
their applicability on screening programs using an abbreviated breast MRI protocol
where only early-phase scans are available and assessment is based only on morphol-
ogy. Moreover, it is questionable whether these existing CADe systems are able to fully
exploit the morphological information. In a previous study133, where 395 lesions were
included from 325 patients, it was shown that the performance of the computer-aided
diagnosis system mainly relied on the dynamic features, whereas, in clinical assessment,
morphology is the most vital information and dynamic information is auxiliary. Auto-
matic evaluation of lesion morphology in a conventional CADe system is dicult, since
it requires design of specic features to be extracted from images. Furthermore, design-
ing such features is known to be the most dicult part and main performance limiting
factor of conventional computer vision systems. Recently popular deep learning meth-
ods tackle this diculty by learning such features automatically based on examples,
instead of using human-engineered features, often using convolutional neural networks
(CNN). This approach turned out to be a ground-breaking success in computer vision
compared to the traditional methods33,128. In accordance to the mentioned advances in
the computer vision eld, medical image analysis has also extensively beneted from the
deep neural networks34 in various domains such as ophthalmology134, dermatology135,
histopatohology136, brain137, and prostate138 and breast109 MRI. Therefore, in this
study, we focused on developing a CADe system which relies on exploiting the spatial
information available in the early-phase MRI volumes using a deep learning approach.
For this purpose, we developed a fully-automated lesion detection pipeline consisting
of several deep learning components. To our knowledge, this is the rst application of
deep learning to fully automated lesion detection in breast MRI.
We compared the proposed CADe system to a previously developed CADe system
that uses the full dynamic breast MRI protocol (early and late-phase scans)27,132. We
used the same training and test sets as in the study by Gubern-Merida et al.132, which
allowed us to make a direct comparison to the results presented in our previous work.
The test set included lesions visible in prior examinations that were assessed as negative
during screening practice. We report the performance of the proposed CADe system
individually for screening-detected lesions and for lesions that were visible but missed
in the prior MRI examinations, as well as for the overall dataset.
5.2 Materials and Methods 87
5.2 Materials and Methods
5.2.1 Dataset
The training dataset was composed of breast MRI scans of 201 women, who underwent
MRI for various reasons including screening and pre-operative staging. 87 of the MRI
scans contained a total of 95 visible malignant lesions. The average eective radius of
the lesions were 10.8 mm with a standard deviation of 6.2 mm and a range of 2.5 -
29.8 mm. The remaining 114 MRI's were considered normal, since they were scored as
either BI-RADS 1 (n=87) or BI-RADS 2 (n=27) by the radiologists. For the women
with normal MRI scans, at least 2 years of follow up were available with no signs of
breast cancer, and, no previous history of breast cancer or breast surgery was reported.
The testing dataset was composed of MRI scans of women participating in a high-
risk screening program between 2003-2014. Of the 160 women in the test set, 120
had normal MRI scans with no signs for malignancy. These woman had no history of
breast cancer or surgery and had at least 2 years of follow up with no signs of breast
cancer (BI-RADS 1 or 2). The remaining 40 women were diagnosed with breast cancer
detected on MRI, with a total of 42 malignant lesions. These woman also had MRI
examinations performed one year earlier, that were classied as negative (BI-RADS 1
or 2). After detection of the cancers, these prior-negative MRI scans were re-evaluated
retrospectively by two radiologists in consensus. In 24 of these prior scans, lesions were
detected retrospectively, while lesions were not visible in the remaining 16 scans. Of the
24 lesions (of 24 scans) that were detected in the prior-negative scans, 11 lesions were
classied as \visible" (BI-RADS 4/5) and 13 lesions were classied as \minimal sign"
(BI-RADS 2/3) by the two radiologists in consensus. The visible lesions are referred
to as \prior-visible" lesions, whereas the lesions with minimal signs are referred to as
\prior-minimal sign". In total we had 66 lesions in the testing dataset (42 screening-
detected, 11 prior-visible and 13 prior-minimal sign). The lesions in this dataset were
smaller than the ones in the training dataset, since these lesions were detected in a
high-risk screening program. The average eective radius of the lesions in this dataset
were 4.8 mm with a standard deviation of 2.5 mm and a range of 2.0 - 15.8 mm. In
Fig. 5.1 we provided a few examples to these lesions.
The MRI scans included in this study were obtained from 1.5 or 3 Tesla Siemens
scanners using a dedicated bilateral breast coil. A gradient-echo (GRE) dynamic se-
quence was performed to obtain a T1w MRI before the administration of a contrast-
agent [Gd-DOTA (Dotarem, Guerbet, France), at a dose ranging from 0.1 to 0.2
mmol/kg]. Within 2 minutes after the administration of the contrast agent, the rst
post-contrast T1w scan was obtained, which was followed by 3-5 additional T1w scans.
Acquisitions were either in transversal or coronal planes with pixel spacing in 0.664-1.5
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Figure 5.1: A few examples of lesions that were detected in the screening program.
mm range and slice thickness in 1-1.5 mm range. Other MRI acquisition parameters
were 1.71-4.76 ms for echo time, 4.56-8.41 ms for repetition time and 10-25 degrees for
ip angle.
5.2.2 Annotation
All lesions were annotated by radiologists in an in-house developed dedicated breast
MRI workstation, which includes a semi-automated tool \smart opening"36,38 for lesion
segmentation. With this tool, a 3D lesion segmentation is obtained after the annotator
places a seed-point at the center of a lesion. Annotators were able to add more seed-
points when the result was not satisfactory especially for the large lesions. Each lesion
was classied by the annotators as mass or non-mass. Motion-corrected subtraction
volumes were used in this process27.
5.2.3 Pre-Processing
For each MRI examination, post-contrast T1w volumes were registered to the pre-
contrast T1w volume to correct for motion using the Elastix toolbox139. Subsequently,
the subtraction volume was obtained by subtracting the pre-contrast image from the
motion-corrected rst post-contrast image. The relative enhancement (RE) volume was
also obtained, which is computed by normalizing the subtraction intensities relative to
the pre-contrast intensities using the following equation:
RE =
I1 - I0
I0
, (5.1)
where I0 and I1 are the intensity values in pre-contrast and motion-corrected rst post-
contrast images, respectively.
5.2.4 Automated Lesion Detection
The automated lesion detection system developed in this study, as illustrated in Fig.
5.2, uses two images as inputs: the pre-contrast T1w volume and the RE volume. Given
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Figure 5.2: Pipeline for the proposed CADe system. It uses two inputs: the pre-contrast volume to
be used in breast segmentation, and the registered rst post-contrast RE volume. Lesion candidates
which are detected in the segmented breast region are classied in the last step.
these inputs, the lesions are detected in 3 steps. Initially, the breast is segmented based
on the pre-contrast T1w image, and subsequently, this segmentation mask is applied to
the RE image. At the second step, a candidate detection algorithm uses the RE image
to search for possible candidate locations within the segmented breast. Here we dene
use the term \candidate" as a voxel or location which is expected to represent a lesion
in its local neighborhood in the breast MRI volume. At the nal step, the candidates
are classied in order to reduce the false positives of the previous stage.
Breast Segmentation
A fully automated breast segmentation method based on deep learning109 was used in
this study to segment the breasts in MRI volumes. This method is based on a 2D
U-net architecture81. U-net is a fully convolutional network which produces "dense
prediction". In other words, for each pixel or voxel in the input image, U-net generates
a likelihood value, which is a useful property for segmentation or detection problems.
In a U-net, this is achieved by the use of de-convolutional part of the network that
comes after the convolutional part, where the output of the convolutional part is up-
sampled. Each axial slice is provided individually to this algorithm to generate the
corresponding likelihood map, where a voxel value in this map indicates the likelihood
of the voxel to belong to the breast. The nal segmentation for an axial slice is obtained
by thresholding the likelihood values at 0.5. The 3D segmentation of the breasts are
obtained by combining these 2D segmentation slices into a 3D volume.
Candidate Detection
In order to detect candidate locations, we followed a similar approach as the one used
to segment the breasts. We trained a 2-level version of the same U-net that was used in
the breast segmentation algorithm, using axial slices to identify the voxels that belong
to a lesion. For this purpose, the lesion segmentations manually generated by the
radiologists were used as the ground-truth. 20% of the training dataset was separated
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Figure 5.3: U-net candidate detection example for an MRI slice. The left image is the corresponding
slice in the breast-segmented RE volume. The right image corresponds to the lesion likelihood map
for the same slice, output by the candidate detection U-net. Contours on both images represent the
segmented lesion for this slice.
at patient level to be used as a validation set. The U-net was trained in batches of
40 randomly selected axial slices: 20 slices containing a segmented lesion and 20 slices
without a segmented lesion. The slices for each batch were randomly selected from
the entire dataset, where the total number of slices containing a segmented lesion was
4106. The loss function used during training was the log of the absolute value of the
dierences between the target and output likelihood values, averaged over the breast
region of the given slice. We used Glorot-uniform initialization82 for weights of the
U-net and RMSProp140 for gradient-descent optimization. The initial learning rate was
set as 0.001 and it was divided by 10 at each 1000 iterations. We continued training
until the loss in the validation set was stable. The resulting trained U-net, given an
MRI axial slice, outputs a likelihood map for each voxel of the given MRI slice to belong
to a lesion. An example result for an MRI slice is given in Fig. 5.3. Subsequently, we
obtained a likelihood volume for each MRI, combining these 2D likelihood maps. The
nal candidates were obtained by applying a local maxima algorithm27 on the likelihood
volumes.
Candidate Classication
In the rst candidate detection stage a set of candidates was obtained based on 2D
shapes and patterns, since the U-net was applied in slice-by-slice basis. In the sec-
ond and nal step, the likelihood for each candidate is further rened to reduce false-
positives. For this purpose, we employed a 3D CNN that uses two types of information
available in the RE volumes: 3D spatial (morphological) information in the local region
around the candidate, and the information arising from the asymmetry between the
enhancements of the two breasts.
In previous work141{143, it has been shown that lesion detection accuracy can be
5.2 Materials and Methods 91
Figure 5.4: Given a location (x1,y1,z1) in the coordinate system of one breast, the corresponding
location (x1,y1,z1)
s in the contralateral breast was identied. Each coordinate system had the origins
at CoG of the breast and they were mirrored to each other along the medial plane.
improved by taking symmetry information of the contralateral breast into account. In
Ref.142,143, this symmetry information was incorporated in a patch-based scheme. We
followed a similar approach to exploit the symmetry information in a patch-based fash-
ion. For each candidate location in a breast, we computed the corresponding location
in the contralateral breast, using the breast masks obtained in the breast segmentation
stage. As illustrated in Fig. 5.4, we initially computed the center of gravity (CoG) for
each breast. We considered the CoG of a breast as the origin of a 3D coordinate system
for the given breast. The coordinate systems for right and left breasts were mirrored
with respect to the median plane. The location of the candidate in this coordinate
system was applied to the coordinate system of the contralateral breast to nd the
corresponding location of the candidate.
For each candidate, a patch of 39x39x39 voxels around the candidate location and
a patch of the same size around the corresponding location in the contralateral breast
were extracted. These two patches were input to a 3D CNN, which was trained to
classify positive and negative candidates. The selection of the patch size was based on
the consideration to include sucient contextual information while keeping the compu-
tational complexity at a reasonable level. The use of an odd number was for practical
reasons, to include regions around the candidate in a symmetric way. The architecture
of the CNN used for this purpose is illustrated in Fig. 5.5. For each of the two inputs,
we used 2 convolutional layers of 5x5x5 with rectied linear unit (ReLu) transfer func-
tions, each followed by a maxpooling layer of size 2x2x2. This was followed by a fully
connected (dense) layer with a ReLu transfer function. These two streams correspond-
ing to the two inputs shared the same weights and they were combined to be input to
a second dense layer with a ReLu transfer function. A nal dense layer with softmax
transfer function was used to compute the nal likelihood values.
We used a validation set to determine the hyper-parameters of the network and the
training process, and to monitor the performance during training. For this purpose,
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Figure 5.5: The CNN used in the study. There are 2 convolutional, 2 max-pooling and 1 dense layer
for each input, where the weights are shared. After the two streams are concatenated, an additional
dense layer and a nal softmax layer is used to obtain lesion likelihood values (L) for each candidate.
20% of the training dataset was randomly selected at case level. Area under the ROC
curve (AUC) was used to measure the performance in this set. We used Glorot-uniform
initialization82 for weights of the network and RMSProp140 for gradient-descent opti-
mization. Drop-out was applied to the last dense layer with a rate of 0.85 and a starting
learning rate of 0.001 was selected. At each batch we used 32 positive and 32 negative
candidates, which were randomly selected from the entire dataset. As the training con-
tinued, the learning rate was dropped by half when the performance in the validation
set did not improve further for 50 epochs, where each epoch consisted of 8 batches. The
training was stopped when the performance in the validation set was not improved in
the last 200 epochs. The nal model was selected as the model resulting in the high-
est area under the ROC curve (AUC) on the validation set. For data augmentation,
we applied random translations (maximum 5 voxels in each direction), rotations and
mirroring to the input patches.
5.2.5 Experiments and Evaluation Method
Experiments
We compared the proposed CADe system to an existing CADe system27. This system
uses the full dynamic breast MRI protocol: the pre-contrast and all registered post-
contract images. It consists of the following steps: breast segmentation, candidate
detection and false positive reduction. For breast segmentation, an atlas-based method
was used. For the rst stage detection, a likelihood map of the MRI was produced using
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a voxel classier, which was trained using several RE and blob feature maps. Using this
likelihood map, candidates were extracted using the local maxima algorithm which was
also used in the presented study. Finally, false positives were reduced in a second-stage
classier, which used both morphological and contrast-dynamics information. Note that
this system was trained and tested on the same datasets as the ones used to evaluate
the presented pipeline.
In order to study the eect of symmetry information on the performance of the pro-
posed CADe system, we trained another 3D CNN which only uses the candidate patch
coming from the suspicious breast as an input. The input for the contralateral patch
and its corresponding stream was removed from the CNN and training was performed
using the same hyperparameters. We refer to this system as CAD-WoS, where WoS
stands for \without symmetry information".
We reported the performance of the proposed system for dierent lesion types (mass-
like and non-mass-like lesions) and for dierent lesion subsets (screening-detected, prior-
visible and prior-minimal sign lesions).
We used the Titan X graphical processing unit (GPU) of NVIDIA R for deep learning
experiments.
Evaluation Method
A candidate was considered as a true positive when its location is within the manu-
ally segmented volume of a lesion, and it was considered as a false positive otherwise.
When multiple candidates hit the segmented volume of a lesion, the candidate with the
highest likelihood was chosen. We used free-response operating characteristic (FROC)
analysis to assess the performance of the evaluated systems. For each threshold level
on the nal likelihood values of the candidates, the average number of false positives in
normal images in the test set was computed. To obtain a nal performance metric for
the system, we used the computation performance metric (CPM)144, where sensitivity
values at 1/8, 1/4, 1/2, 1, 2, 4 and 8 false positives per scan were averaged145{149.
Statistical comparison between two FROC curves was performed using the boot-
strapping method150. We sampled cases 1000 times with replacement and constructed
the FROC curves for the two systems based on these samples. For each bootstrapped
curve, we computed the dierence between CPM values ( CPM). The p value for
a statistical comparison was dened as the number of the negative or zero valued 
CPM's divided by the number of samples, 1000. We used Bonferroni correction for
3 comparisons. The dierence between two CPM values was considered as signicant
when the p value was smaller than 0.05/3.
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5.3 Results
The FROC plots for the proposed CADe system with and without symmetry infor-
mation, and for the previous CADe system are given in Fig. 5.6. The CPM value
obtained by the proposed CADe system was 0.6429 0.0537, which was signicantly
higher than the CPM value of 0.5325 0.0547 obtained by the previous CADe system
(p = 0.008). The CPM value obtained by the CADe-WoS was 0.5804 0.0572. The dif-
ferences in CPM values between the previous CADe system and the CADe-WoS system,
and between the proposed CADe system and CADe-WoS system were not statistically
signicant (p > 0.05/3).
Figure 5.6: FROC plots for the proposed CADe system, CADe-WoS system and the previous CADe
system.
The FROC plots for dierent lesion subsets are given in Fig. 5.7. Corresponding
CPM values are given in Table 5.1. CPM values increased in all lesion subsets compared
to the CPM values obtained by the previous CADe system. We observed the most
remarkable performance improvement compared to the previous CADe system in the
prior-visible lesions (CPM increase from 0.4675 to 0.6623) and in the non-mass lesions
(CPM increase from 0.4935 to 0.5844).
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Figure 5.7: Comparison of performances of the two CADe systems in dierent lesion subsets: (a)
screening-detected, prior-visible and prior-minimal sign lesions and (b) mass and non-mass lesions.
Table 5.1: CPM values for dierent lesion types.
Previous CADe Proposed CADe
All Lesions 0.5325 0.6429
Screening-detected 0.6803 0.7357
Screening-detected mass 0.7685 0.8253
Screening-detected non-mass 0.4935 0.5844
Prior-visible 0.4675 0.6623
Prior-minimal sign 0.2308 0.2747
5.4 Discussion
In this study we developed a fully automated CADe system for breast MRI using
deep learning. Our purpose was to exploit the spatial information obtained in the
early-phase as much as possible, without using the temporal information from the late-
phase of the contrast enhancement. We followed a deep learning approach, since deep
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learning has advantages over the conventional computer vision methods, such as using
automatically learned features rather than hand-crafted features to evaluate spatial
information. The proposed CADe system obtained a CPM score of 0.6429, which was
signicantly (p=0.008) higher than the CPM score of 0.5325 obtained by the previous
CADe system that used the full dynamic breast MRI protocol.
The developed CADe system uses symmetry information arising from the dier-
ences between the contrast enhancements of the two breasts of the same woman, in
addition to the 3D morphological information in the candidate regions. A previous
study which used symmetry information for automatically detecting lesions in breast
MRI had shown its benet for DCIS lesions141. Dierent than the referred study, we
used symmetry information in a deep-learning scheme using a similar method as em-
ployed for mammography images142, albeit in 3D. Our results showed that symmetry
information contributes to improve the overall performance of the CADe system (CPM
values of 0.6429 and 0.5804 with and without using symmetry information, respec-
tively). This was expected, since symmetry information is also used by the radiologists
to assess lesions and it is stated in the guidelines.105. The performance of the CADe
system without symmetry information was still higher than the performance of the
conventional CADe system that uses the full dynamic breast MRI protocol.
The CNN architecture we used in the candidate classication stage was not very
deep, including 2 convolutional layers with 5x5x5 sized lters and 2 dense layers. This
is similar to the LeNet532, which was developed for handwritten digit recognition,
except that we used a 3D CNN. In our experiments we found that it was essential to
limit the complexity of the model in order to prevent overtting, even when a high
drop-out rate was used for regularization. This may be related to the limited amount
of data used for training. Deeper networks are useful in natural images as they include
complex hierarchical relations that require many layers of representations. Although
this may not be the case for medical images, in particular for MRI scans, more complex
and deeper models may still be useful in the presence of a large amount of data.
To reect a real screening situation, we evaluated the performance of the developed
CADe system on a test set including cancer and normal cases from woman participating
in a high-risk screening program with MRI. However, the training set did not include
screen-detected cancers because we did not have them available at the time of the study.
Occurrence of malignant lesions in screening breast MRI scans is much less frequent
compared to the diagnostic MRI scans. The test set included lesions that were visible
or had minimal signs in prior scans, which allowed us to test the performance of the
system for lesions that were overlooked or misinterpreted by the radiologists. The most
remarkable increase in detection performance was observed in lesions visible in prior
MRI scans (see Fig. 5.7 and Table 5.1). The proposed CADe system was able to
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detect 60% more lesions compared to the conventional CADe system at the threshold
equivalent to 1 false positive per scan. This suggests that the proposed CADe system
might be more useful to prevent reading errors.
We also tested the performance of the proposed CADe system individually for mass-
like and non-mass-like lesions (see Fig. 5.7 and Table 5.1) within the screening-detected
subset of the test set. We observed a performance increase in detection of both lesion
types. However, the detection performance for non-mass lesions was still lower than
that for the mass lesions. More training data of non-mass lesions and the development of
dedicated algorithms may be needed to increase detection performance for such lesions.
Our study has some limitations. We did not evaluate how the addition of contrast
dynamic information may improve the performance of the presented CADe system.
Although contrast dynamic information from the late-phase may not be available in
a screening setting, novel fast MRI acquisition protocols make it possible to obtain
dynamic contrast uptake information in the early-phase of the acquisition, which does
not cause an increase in the duration of the breast MRI. It should be investigated
in a further study whether the addition of such early-phase dynamic information can
increase the detection performance of a CADe system. Additionally, we assumed that
the two breasts have the same (mirrored) shapes to identify corresponding locations in
the contralateral breasts. Although this assumption holds for most of the cases, some
patients may have asymmetric breast shapes. In the future we will investigate more
advanced registration methods that take into account the dierences in shapes between
the right and left breasts of a given woman.
In conclusion, we developed a CADe system for breast MRI which uses only the
early-phase of the acquisition without using dynamic information from the late-phase
T1w acquisitions. In order to fully exploit the spatial information obtained in the
early-phase, we used 3D morphology of the candidate regions and symmetry between
the enhancements of two breasts of the patient, using a deep-learning approach. The
proposed CADe system signicantly outperformed a conventional CADe system which
uses the full dynamic breast MRI protocol. The developed CADe system can be used in
novel abbreviated MRI protocols that have been suggested for MRI screening programs.
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Abstract
We investigated articial intelligence (AI) based classication of benign and malignant
breast lesions imaged with a multi-parametric breast MRI protocol with ultrafast DCE-
MRI, T2-weighted (T2w) and diusion weighted imaging (DWI) with apparent diusion
coecient (ADC) mapping.
We analyzed 576 lesions, including a consecutive set of 368 malignant and 149 be-
nign biopsy proven lesions, and an additional set of 59 follow-up proven benign lesions
imaged with MRI. The MRI protocol included ultrafast DCE, T2-weighted (T2w) and
diusion-weighted imaging (DWI) sequences. We used deep learning methods to in-
terpret ultrafast DCE and T2w information. A random forests classier combined the
output with patient information (PI) (age and BRCA status) and apparent diusion
coecient (ADC) values obtained from DWI to perform the nal lesion classication.
We used receiver operating characteristic (ROC) analysis to evaluate our results. Sensi-
tivity and specicity were compared to the results of the prospective clinical evaluation
by radiologists.
The area under the ROC curve (AUC) was 0.811 using only ultrafast dynamics. The
nal AI system that combined all imaging information with patient information resulted
in an AUC of 0.852, signicantly higher than the ultrafast dynamics alone (p=0.002).
When operating at the same sensitivity level of radiologists in this dataset, this system
correctly classied 78 of the all benign lesions as benign, in contrast to the 59 non-
biopsied benign lesions which were true negatives on basis of follow-up information .
At the same sensitivity point as the radiologists, the best performing classier achieved
a slightly higher specicity of 0.375 (78/208), which translates to 19 more benign lesions
for which biopsies could have been prevented (i.e. 12.7%) (p=0.072).
Use of adjunct imaging and patient information has a signicant contribution in
diagnostic performance of ultrafast breast MRI. The developed articial intelligence
system for interpretation of multi-parametric ultrafast breast MRI may improve speci-
city.
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6.1 Introduction
Dynamic-contrast enhanced (DCE) magnetic resonance imaging (MRI) is an indis-
pensable modality in breast imaging with an unmatched sensitivity for breast cancer
detection. While a meta-analysis reported an overall sensitivity of 90%, later advances,
such as introduction of 3T scanners, have increased the sensitivity of DCE-MRI to even
higher levels8. However, not only malignant lesions, but also benign structures enhance
in breast DCE-MRI, which makes the interpretation of lesions an important task.
Lesions are primarily interpreted based on their morphologic and dynamic char-
acteristics on dynamic contrast enhanced T1-weighted sequences. Obtaining dynamic
information of lesions requires acquisition of multiple post-contrast volumes in order to
observe the changes in enhancement over time. Traditionally, the washout of contrast
agents from lesions is reported, which requires acquisition of T1 weighted images up
to about 7 minutes after contrast administration. Novel ultrafast DCE-MRI sequences
allow monitoring of the uptake of the contrast agent, instead of imaging washout at
the late phase, thus reducing the scan-time and therefore costs associated to breast
MRI12{14.
Previous studies have demonstrated that the diagnostic accuracy of \maximum
slope" or \time-to-enhancement" features of the contrast uptake curve obtained with
ultrafast protocols, outperform the conventional evaluation of the late phase dynamics
(\curve type")15,151. Therefore, these novel sequences are rapidly implemented in clin-
ical breast MRI. Consequently, in this study, we used ultrafast DCE-MRI as the basis
for breast lesion evaluation.
In addition to the 4-dimensional (4D) DCE-MRI series in a breast MRI protocol,
diusion-weighted imaging (DWI) and T2-weighted (T2w) volumes are acquired in or-
der to increase specicity further in clinical breast MRI protocols. Apparent diusion
coecient (ADC) values obtained from DWI volumes have been shown to provide ad-
junct information that enables reduction of the frequency of false positive biopsies152,153.
Combining T2w images of lesions with DCE-MRI characteristics can also improve di-
agnostic accuracy17,154.
The high dimensional and multi-parametric nature of the information currently ob-
tained in breast MRI makes interpretation still complex and labor-intensive. In ad-
dition, inter-observer variations are common. The use of computer-aided diagnosis
(CAD) systems may improve diagnostic accuracy by decreasing inter-observer varia-
tions, providing support for clinical decisions and reducing the number of false-positive
biopsies155,156. This is likely improved by the advent of the recently popular and pow-
erful articial intelligence (AI) techniques known as deep learning. In this study we
therefore investigated whether automated classication of benign and malignant le-
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sions in multi-parametric ultrafast breast MRI using deep learning techniques enables
further reduction of false positive biopsies.
6.2 Materials
6.2.1 Study Dataset
Cases were collected by retrospective evaluation of all consecutive patients undergoing
breast MRI at the Radboud University Medical Centre, Nijmegen, the Netherlands
from October 2011 to December 2016. Indications for breast MRI at our institution
were screening of women with high and intermediate risk of developing breast cancer,
preoperative staging in women with an invasive lobular carcinoma, an invasive carci-
noma under the age of 50, women with indeterminate tumor size, women who were
considered candidates for neoadjuvant treatment, problem solving in women with nd-
ings that could not be resolved by biopsy, and evaluation in women with lymph-node
metastasis with an unknown primary tumor. Based upon a per-patient coupling to the
national pathology database (PALGA)157, we included all biopsied lesions in our study.
This yielded 368 malignant and 149 benign lesions, all proven by histopathology. Nine
of the malignant lesions were not detected by the radiologists who were evaluating the
MRI in routine diagnostics, but by other means at a later point in time. Therefore, the
lesions visible in these MRIs containing these lesions were missed or misinterpreted at
the time of routine evaluation. Consequently, the sensitivity of the radiologists report-
ing the MRI scans in this dataset was 0.975 (359/368). Additionally, we selected all
non-biopsied lesions from the MRI studies before 2012 that were classied as BIRADS-2
by the reporting radiologist and remained stable with at least 2 years of follow-up. This
resulted in an additional 59 benign lesions and thus creating an articial specicity of
0.284 (59/208). In total, we included 576 lesions from 492 breast MRI examinations
performed in 465 women. The age of the women ranged from 21 to 89 with an average
of 50.2. Eighty-six women were known BRCA1 or BRCA2 gene mutation carriers.
6.2.2 MRI Protocol
A 3T MR scanner (Siemens Magnetom Trio/Skyra, Erlangen, Germany) with a 16-
channel breast coil (Siemens) was used for all examinations. The breast MRI protocol
consisted of T1-weighted (T1w) DCE-MRI, DWI and T2w imaging. In the analyzed
timespan, all breast DCE-MRI acquisitions were performed using a bi-temporal proto-
col, which incorporated an ultrafast TWIST acquisition during the inow of contrast
agent, followed by a conventional DCE-MRI series (VIBE) during the late phase of con-
trast enhancement. As previous research showed that automated analysis of TWIST
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outperforms that of VIBE and our research did not nd incremental value in combin-
ing both DCE series, we focused on ultrafast TWIST volumes in this study15,36,133,158.
Acquisition parameters of the breast MRI protocol are given in Table 6.1.
Table 6.1: Acquisition parameters used in the breast MRI protocol. FOV, eld of view; TE/TR, echo
time/repetition time; FA, ip angle; NA, not applicable.
Parameters DWI TWIST VIBE T2
Spatial Resolution (mm) 1.5 x 1.5 x 4 1.0 x 0.9 x 2.5 0.9 x 0.8 x 1.0 1.3 x 1.1 x 2.5
Temporal Resolution (s) NA 4.32 80 NA
Number of Volumes 1 20 5 1
FOV (mm) 340 360 360 340
TE/TR (ms) 60/6400 2.2/3.96 1.71/5.5 143/3220
FA NA 20 20 80
b-values 50, 800 NA NA NA
Fat suppression SPAIR NA NA NA
6.2.3 Annotation and Patch Generation
All lesions were manually annotated by placing a marker at the lesion-center under
the supervision of an expert breast radiologist, with access to other breast imaging
exams, radiological and histopathological reports. For multi-focal or very large lesions
we placed multiple markers and considered these as separate regions (Fig. 6.1). The
nal evaluation for such lesions was based on averaging their results. For each lesion,
annotations were initially placed on subtraction volumes obtained from TWIST series,
then in T2w volumes and nally in ADC volumes. At each step, the marker placed in
the previous step was given. The markers were only adjusted in the present volume if
necessary due to misalignments caused by patient motion or image distortion. Adjust-
ment was needed mostly for marker positioning in the ADC volumes. This is due to
regular presence of some distortion artifacts caused by the eddy currents in the DWI
acquisitions, and therefore the calculated ADC volumes.
A cubic 3D patch with axes of 5 cm centered on the location of the marker was
extracted from the corresponding MRI volume. For the dynamic series TWIST, we
extracted the patches from subtraction volumes obtained from the pre-contrast volume
and each post-contrast volume. Therefore, for each lesion, we obtained a set of 3D
patches consisting of 19 patches from TWIST, 1 patch from T2w and 1 patch from
DWI volumes.
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Figure 6.1: An example of multifocal lesions for which more than one annotations were used (shown
in red). Annotations are initially placed on the TWIST subtraction volumes. Then, these initial
annotation points are available in T2-weighted and apparent diusion coecient (ADC) volumes at
the same coordinates. User is able to select an annotation and change its position, which was mostly
needed in the ADC volumes due to image distortions. Results obtained from multiple annotations of
the same lesion were later averaged.
6.2.4 Deep Learning Based Classication System
In this study, we used the \DenseNet" deep learning architecture as it is considered
to be one of the best performing architectures and known to be less prone to over-
tting compared to others159. The dierence of the DenseNet architecture compared
to other architectures is in its reuse of lters. A DenseNet is mainly composed of
blocks of densely packed convolutional layers, where `dense' refers to the fact that each
convolutional layer reuses the lters of the previous layers in the same block. Each
layer also introduces new additional lters, the number of which is determined by the
hyper-parameter growth rate. Reuse of lters reduce the number of parameters used
in the network which in return reduces the risk of overtting. To limit the number of
parameters further, `bottleneck layers' are also used between the convolutional layers
and between the blocks, where a `bottleneck layer' refers to the convolutions with a
kernel size of 1, reducing the number of channels being input to the subsequent layers.
Other than the mentioned blocks, there is also an initial convolutional layer and nal
fully connected and average pooling layers.
To adapt this architecture to the problem of interest, we implemented a 3D version of
DenseNet with 2 blocks each having 3 convolutional layers. Therefore each convolutional
lter had a kernel size of 3x3x3 and max-pooling layers had a kernel size of 2x2x2. We
used 32 lters at the initial convolutional layer and used a growth rate of 16. We used a
single dense layer and a subsequent softmax layer to generate the nal likelihood values.
To initialize the weight parameters of the network, we used He initialization160. For
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optimizing the weights, we used stochastic gradient with Nesterov momentum of 0.9.
During training we used a batch size of 16 and an initial learning rate of 0.001 which was
divided by 10 after the 50th epoch. Based on the empirical observation that validation
performances reach to a plateau after at most 70 epochs, we trained all networks for a
xed number of 100 epochs. During training we applied several augmentations to the
input patches: random 2D rotations with an angle randomly selected, mirroring and
translations that are up to 2 voxels.
We trained independent convolutional neural networks (CNNs) for TWIST and T2w
patches, which are described in more detail below. For DWI, we extracted ADC val-
ues for each lesion using a method based on thresholding and averaging. Finally, we
combined likelihood values obtained from CNNs, ADC values and patient information
(age and BRCA gene status) using random forests classiers in order to obtain a nal
malignancy score for each lesion. Fig. 6.2 provides a general illustration of this system.
We preferred using random forests at this stage since these classiers are considered
robust against overtting and hyper-parameter selection50. We used the OpenCV im-
plementation161 of the random forests classier algorithm. The maximum number of
trees was set to 1000 while the other hyperparameter values were the default values of
the OpenCV implementation.
Training CNNs for 4D ultrafast DCE-MRI and 3D T2w Volumes
In clinical practice the information of ultrafast DCE-MRI is not obtained per volume,
but rather from the changes of enhancement in the volume over time (i.e. in 4D),
which yields the time to enhancement and the relative enhancement versus time curve
for each lesion151. To enable the use of a 3D CNN for the analysis of this 4D data,
we initially reduced 4D information from ultrafast DCE-MRI to 3D. This was done by
creating maximum intensity projections (MIP) of each ultrafast 3D patch, resulting in
a 2D image. Subsequently, by stacking all 2D MIP images corresponding to dierent
time-points of the same lesion into a single 3D patch, we created a new ultrafast 3D
patch where the third dimension is time. The ultrafast 3D patch was used as input for
the CNN. Fig. 6.3 provides a schematic overview of the generation of these 3D volumes.
In this way, we were able to perform spatiotemporal analysis using a 3D CNN on these
patches. We refer to this CNN as \DYNA CNN".
For the automated analysis of T2w volumes, a second 3D CNN using the same
DenseNet architecture was trained on the patches extracted directly from the T2w
volumes. We refer to this CNN as \T2w CNN". The likelihood values obtained from
\DYNA" and \T2w" CNNs were used as features in the nal random forests classier.
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Figure 6.2: The machine learning system used for classifying lesions. A random forests classier
combines information obtained from three dierent MRI sequences and patient information. Patches
were created for TWIST and T2w volumes to be evaluated in 3D CNNs, while ADC values were
directly used in the nal classier, together with the likelihood values obtained from CNNs. MRI,
magnetic resonance imaging; CNN, convolutional neural network; ADC, apparent diusion coecient.
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Figure 6.3: Pipeline for processing ultrafast dynamic contrast-enhanced magnetic resonance images
(DCE-MRI). The following steps were followed to obtain these nal 3-dimensional patches from sub-
traction volumes: 1. For each patient, we used the only post-contrast volumes that are obtained after
the time-point that contrast agent arrives at the ascending part of the aorta (tAorta), for temporal
normalization. Since the most important information in ultrafast MRI is how fast the lesion enhances,
it is important to normalize the imaging data so that all breasts are aligned in terms of the time that
contrast agent arrives to the breast tissue. For this purpose we recorded the rst time-point where
contrast agent is visible in aorta and we included 13 subtraction volumes starting from this time-point.
2. For each of the 3D subtraction patches, we applied maximum intensity projection (MIP) through
the axial direction, producing 13 2D MIP subtraction patches. 3. Finally we concatenated 2D patches
into a single 3D patch, where the third dimension is time.
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Extraction Per-lesion ADC values from ADC volumes
For each annotated point in the ADC volumes we computed an ADC value that takes
the neighboring voxels into account. For this purpose, we initially selected a sphere
around the annotated point with a radius of 4 mm, equaling the slice thickness. To
ensure the exclusion of the fatty tissue from the computation, we selected only the voxels
over a threshold of 0.2 103 mm2s-1 within the sphere and computed the average ADC
value over the selected voxels. This threshold was determined based on the reported
distribution of ADC values obtained using a 3T MRI scanner162. This provides an ADC
value for each annotation on the ADC volumes. For the large or multi-center lesions
that had multiple annotated points, we averaged the ADC values that were obtained
for each annotation point.
6.2.5 Statistical evaluation
For the multi-focal and very large lesions, the average of the likelihood values was used.
The same approach was followed for ADC values. A nal system combining all available
information (ADC values, patient information and the likelihood values obtained from
DYNA CNN and T2w CNN) was created by training a random forests classier.
We used receiver operating characteristic (ROC) analysis to evaluate performances
of the individual CNNs and the obtained ADC values. Their discriminative capacity
between benign and malignant disease was trained and tested in a 5-fold cross validation
(CV) scheme, using a patient-wise separation in folds. The same CV folds were used in
all experiments. Training processes for the CNNs were continued until the losses did not
decrease further. Bootstrapping was used to calculate the area under the ROC curve
(AUC) values and to compute 95% condence intervals. We combined the components
using the aforementioned random forest classier, and calculated AUC values for the
dierent combinations, also including patient specic information (age and the presence
of a BRCA gene mutation). To compare the ROC curves bootstrapping was again used.
6.3 Results
6.3.1 Patient and Lesion Characteristics
Characteristics of the lesions and patients included in the dataset is summarized in
Table 6.2. More detailed pathological information was available for most of the biop-
sied lesions. Accordingly, there were 215 invasive ductal carcinomas (IDC), 78 invasive
lobular carcinomas (ILC) and 45 pure in situ ductal carcinomas (DCIS) in the dataset.
Other malignant lesions included papillary, tubular, apocrine, adenoid cystic, meta-
plastic carcinomas and malignant adenomyoepithelioma. Of the 300 invasive lesions
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Table 6.2: Patient and lesion characteristics included in the study. Eective diameter is measured
based on the segmented volume of the lesion.
Lesions Malignant Biopsied Benign Non-biopsied Benign
Number of lesions 368 149 59
Average eective diameter (mm) 13.6 (7.5) 12.0 (7.5) 8.3 (3.5)
Number of patients 318 112 35
Average patient age 52.8 (12.0) 44.6 (12.5) 47.5 (11.2)
BRCA 1/2 gene mutation carriers 34 (11%) 23 (29%) 10 (28%)
with known molecular subtype based on receptor status, 246 (82,0%) were luminal
type (estrogen receptor (ER) and/or progesterone receptor (PR) positive), 32 (10,7%)
were basal type (triple negative; ER, PR and human epidermal growth factor receptor-2
(HER2) negative) and 22 (7,3%) were HER2 type (ER/PR negative and HER2 posi-
tive). For the 333 lesions with known histopathologic grade, 44 (13,2%) lesions were
grade 1, 168 (50,5%) lesions were grade 2 and 121 (36,3%) lesions were grade 3. Of
the 112 biopsied benign lesions, 39 (34,8%) were broadenomas. The other benign
lesions included various pathologic diagnoses, such as brosis, adenosis, cysts, lobular
carcinoma in situ, ductal hyperplasia, sclerosis, and hamartoma.
6.3.2 Classication Results
The best classication performance was obtained by combining all imaging and patient
information (PI), achieving an AUC of 0.852, which was signicantly better than the
performance of the best performing component (DYNA CNN: AUC of 0.811, p = 0.002).
The ROC curve for this nal system is given in Figure 6.4. The radiologists operating
point on this case-set is also illustrated (sensitivity 0.975, specicity 0.284). At the same
sensitivity point, the best performing classier achieved a slightly higher specicity of
0.375 (78/208), which translates to 19 more benign lesions for which biopsies could have
been prevented (i.e. 12.7%). However, this dierence was not statistically signicant
(p=0.072).
Table 6.3 shows the AUC values obtained when each component of the machine
learning system is used independently. The corresponding ROC curves are given in
Figure 6.4-a.
We also experimented with classication based on non-contrast information, i.e.,
imaging information that is obtained without any contrast agent (ADC and T2) and
PI. Figure 6.4-d includes the resulting ROC curves for these combinations. An AUC
value of 0.748 was obtained when all non-contrast information was used, as given in
Table 6.4.
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Table 6.3: Area under the ROC curve (AUC) values with 95% condence intervals for the individ-
ual information components of the machine learning system. ROC, receiver operating characteristic;
DYNA CNN, convolutional neural network based on dynamic-contrast enhanced magnetic resonance
imaging; PI, patient information; ADC, apparent diusion coecient.
Component AUC Values
DYNA CNN 0.811 (0.768-0.846)
T2w CNN 0.596 (0.538-0.65)
ADC 0.611 (0.542-0.664)
PI 0.680 (0.626-0.733)
Table 6.4: Area under the ROC curve (AUC) values with 95% condence intervals for the individ-
ual information components of the machine learning system. ROC, receiver operating characteristic;
DYNA CNN, convolutional neural network based on dynamic-contrast enhanced magnetic resonance
imaging; PI, patient information; ADC, apparent diusion coecient.
Component AUC Values
T2w CNN and ADC 0.667 (0.614-0.716)
T2w CNN and PI 0.704 (0.651-0.756)
ADC and PI 0.745 (0.695-0.796)
T2w CNN, ADC and PI 0.748 (0.697-0.797)
Table 6.5 provides the AUC values when dierent components are combined with
the results of DYNA CNN using a random forests classier. ROC curves for the com-
binations with DYNA CNN are given in Figures 6.4-b and 6.4-c.
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Table 6.5: Area under the ROC curve (AUC) values when DYNA CNN was combined with other
components. 95% condence intervals are given in parenthesis. The p-values of the comparisons to
the AUC of DYNA CNN are given in the nal column. ROC, receiver operating characteristic; DYNA
CNN, convolutional neural network based on dynamic-contrast enhanced magnetic resonance imaging;
PI, patient information; ADC, apparent diusion coecient.
DYNA CNN Combined with: AUC Values p-values
- 0.811 (0.768-0.846) -
T2w CNN, ADC and patient information 0.852 (0.807-0.881) 0.002
T2w CNN and ADC 0.831 (0.791-0.867) 0.043
T2w CNN and PI 0.837 (0.797-0.873) 0.031
ADC and PI 0.849 (0.808-0.884) 0.006
T2w CNN 0.816 (0.772-0.85) 0.303
ADC 0.827 (0.784-0.863) 0.061
Figure 6.4: Receiver operating characteristic (ROC) curve for the nal classier. Additionally the
upper and lower curves for 95% condence intervals are also plotted. The sensitivity and specicity of
the radiologists in this dataset is marked with the black dot.
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Figure 6.5: Receiver operating characteristic (ROC) curves for dierent components and combinations.
(a) Individual components used in the nal classier: DYNA CNN, T2w CNN, ADC and PI. (b) When
adjunct imaging and patient information (PI) combined with DYNA CNN, leading to the performance
of the nal classier. (c) When each of the T2w CNN, ADC and PI was individually combined with
DYNA CNN. ROC curve for the DYNA CNN is also provided here for comparison. (d) When non-
contrast components were combined with each other. DYNA CNN, convolutional neural network based
on dynamic-contrast enhanced magnetic resonance imaging; T2w CNN, convolutional neural network
based on T2-weighted imaging; PI, patient information; ADC, apparent diusion coecient.
6.4 Discussion
In this study we showed that the classication of benign and malignant breast lesions
imaged with a multi-parametric ultrafast DCE-MRI protocol using AI techniques is
at least as accurate as dedicated breast radiologists. We used ultrafast DCE-MRI,
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applying state of the art deep learning methods for spatiotemporal analysis of ultrafast
DCE-MRI volumes, DWI and T2w volumes in addition to patient information (BRCA
status and age) in the nal classier. The developed system reached an AUC value of
0.852. When operating at the same sensitivity level as the radiologists in this dataset,
the automated classication yielded 130 false-positives, 19 less than the biopsied benign
lesions in our dataset.
We noticed that there were dierences between the misclassications generated by
the machine learning system and radiologists diagnoses. Only 1 of the 9 false negative
lesions, and, 100 of the 147 false positive benign lesions were detected by both the
machine and the radiologists, which shows the potential of the developed system for
improving diagnostic accuracy when used by radiologists as a decision support tool.
When only using the ultrafast DCE series (TWIST), an AUC value of 0.811 was ob-
tained. Combining it with T2w and ADC information using a random-forests classier
increased the AUC value to 0.831. In previous studies DWI information was found to
be useful in combination with DCE-MRI for increasing the diagnostic accuracy163{166.
Pinker et al.164 reported a high inter-reader agreement for both DWI ( = 0.864) and
DCE-MRI ( = 0.875). In the current study we observed an increase in AUC when
ADC values were combined with DCE-MRI information, although the dierence did
not reach statistical signicance (p=0.061). Zhang et al.165 also reported that T2w
information does not contribute to the diagnostic accuracy signicantly. Similarly we
observed that, compared to T2w, ADC information tends to have more impact on the
classication performance. Using patient information further increased the performance
of the classier. Age and BRCA genes are known breast cancer risk factors167. There-
fore, given a suspicious nding, the likelihood of malignancy should be expected to be
higher for older women or known carriers of a BRCA gene mutation. On the other
hand, Table 2 shows that only 11% of the women with malignant lesions was a BRCA
gene mutation carrier, while this was 29% and 28% for biopsied and non-biopsied benign
lesions, respectively. This is probably due to the retrospective nature of our dataset, for
which inclusion is aected by the same breast cancer risk factors. The random-forests
classier uses this distribution together with suspiciousness scores obtained from the
imaging information, which results in an increase in classication accuracy. Finally, we
experimented using only the information obtained without using any contrast agent, in
other words, excluding DYNA CNN. Combining all non-contrast data lead to an AUC
value of only 0.748, which conrms the importance of DCE-MRI.
In this work, we reduced the 4-dimensionality of the DCE series to 3D by using
2D MIPs. This created a 3D spatiotemporal volume, which is essentially a video of
contrast agent ow in the tissue and is similar to the clinical method for assessing
time-to-enhancement in ultrafast DCE-MRI43,151. Reducing the 4D information of the
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TWIST sequence to 3D allowed us to perform directly spatiotemporal analysis with
deep learning using a 3D CNN.
The most important strength of deep learning methods is their capability to au-
tomatically learn features based on training data. This approach not only eliminates
the need for engineering special features for each image analysis problem, but also
reaches superior performance compared to the traditional methods as the amount of
training data is increased. Previous studies focusing on automated analysis of ultra-
fast DCE-MRI relied on the traditional way of extracting specially designed dynamic
and morphological features36,133,168. Furthermore, contribution of adjunct imaging and
patient information was not considered. Only few studies investigated the use of multi-
parametric information for automated classication of breast lesions. Bhooshan et al.52
and Gallego-Ortiz et al.169 have reported increases in AUC values from 0.80 to 0.85 and
0.80 to 0.83, respectively, when T2w features were used in their CAD systems in ad-
dition to DCE-MRI features. However, their results might not be directly comparable
to ours, as they used the conventional low temporal resolution DCE-MRI acquisitions
with washout dynamics. The slightly higher spatial resolution obtained from these
conventional protocols was not found to result in a higher classication performance
in previous studies36, whereas the ultrafast dynamic data provides improved diagnos-
tic information15,36. Furthermore, in a previous study we found that even combining
the ultrafast dynamic information with the washout information does not result in a
signicant increase in diagnostic performance158. This might explain why the relative
improvement by T2w features is slightly larger in their study.
The main nding of our study, namely the increase in performance of the AI system
by incorporation of multiparametric data highlights the value of multiparametric breast
MRI for lesion classication. Since the AI system and the radiologists did not rate all
lesions equally, the use of the proposed system allows for improving lesion classication
in clinical practice. Furthermore, the use of AI may facilitate integration of the multi-
parametric data of the abbreviated, but still multiparametric, MRI protocol. This may
increase the speed of evaluation by breast radiologists, and, improve cost-eectiveness
of the technique.
Our study has limitations. The imaging data we used was collected from a single
clinical center, which limits the generalizability of the results. We included a set of non-
biopsied benign lesions, but these were not consecutive cases. Especially in a screening
setting, radiologists evaluate a high number and variety of benign lesions and may not
report lesions that are immediately classied as normal. Therefore, the current trained
system might produce dierent performance results when applied to data obtained from
other populations. Future studies should focus on collecting representative, large and
multi-institutional datasets to train and evaluate articial intelligence systems for lesion
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classication including all benign lesions available. Using a larger dataset would also
allow to investigate the use of deeper CNN architectures for improved learning and
classication.
In conclusion, in this study we investigated classication of benign and malignant
lesions imaged with a multi-parametric ultrafast DCE-MRI protocol, using state-of-the-
art articial intelligence techniques. According to our results, the use of adjunct imaging
sequences and patient information signicantly contributes to diagnostic performance.
Articial intelligence based classication may assist radiologists in interpreting these
high-dimensional and multi-parametric images to improve specicity.
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Summary
Breast MRI is an indispensable modality in breast imaging with its high sensitivity for
detecting breast cancers. Although benign lesions also appear in breast MRI, it is pos-
sible to distinguish them from malignant lesions by interpreting them based on their
morphology, contrast-enhancement dynamics and other adjunct information such as
their diusion properties imaged with DWI and their appearance on T2w images. De-
spite its high sensitivity, breast MRI is not used for general breast cancer screening for
several reasons, such as high cost, necessity of using a contrast agent, long acquisition
times and time consuming reading process of the high-dimensional and multiparametric
information that it provides. However, novel DCE-MRI sequences and breast MRI pro-
tocols tackle the problem regarding the acquisition durations using dierent strategies,
such as using smart ways of sampling the k-space in ultrafast DCE-MRI sequences or
abbreviating the acquisition protocol to use only morphology for the interpretation.
Reading eciency of breast MRI can be improved using computer tools that analyze
images automatically by employing machine learning and computer vision methods.
Although there have been several previous studies on computer-aided detection and
diagnosis of lesions in breast MRI18{28, this thesis focuses on novel breast MRI proto-
cols that can be key in wider use of this imaging modality. Furthermore, previously
developed automated analysis systems for breast MRI were based on traditional ma-
chine learning and computer vision methods, while these elds have seen a rapid and
revolutionary transformation in the recent years by the introduction of the algorithms
called `deep learning'. Dierent than the conventional methods that require engineering
of features, deep learning algorithms learn the features specic to the problem based
on training data. It turns out that this approach can outperform conventional methods
especially when there is abundant data for training. As a result, a rapid transition in
computer vision and machine learning elds from conventional methods into deep learn-
ing based methods was observed in the recent years. This transition can also be seen
in this thesis, as we start with conventional methods and continue with deep learning
methods where we provide comparisons to the former.
Chapter 2 of this thesis presents a computer-aided diagnosis system for ultrafast
breast DCE-MRI that classies malignant and benign lesions using traditional image
analysis and machine learning methods. The CAD system extracts dynamic and mor-
phological features for each lesion based on a semi-automated segmentation. Dynamic
features are automatically normalized based on the aortic enhancement time. In our
experiments, this system signicantly outperformed a previously developed system espe-
cially in the dynamic evaluation of the lesions. However, we observed that morphological
evaluation in this system had a relatively poor performance, despite the improvements
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in the segmentation method that denes lesion boundaries. Evaluating morphological
information is dicult with conventional methods, since careful feature engineering is
required to describe the lesions for the classier. Furthermore, dynamic features are
computed voxel-wise, without consideration of the information at neighboring voxels.
This classication problem is revisited later in Chapter 6, where deep learning is used
for a combined spatiotemporal analysis that does not require feature engineering.
We started exploring the use of deep learning methods in automated analysis of
breast MRI by Chapter 3. In this chapter, we adopted a fully convolutional neural net-
work method known as `U-Net' for segmenting breast and broglandular tissue (FGT)
in T1w MRI volumes. Breast segmentation is an important application in automated
analysis of breast MRI, since most of the automated lesion detection algorithms require
it as a prior step to dene the region to search for lesions. Furthermore, measure-
ments such as breast density (BD) or background parenchymal enhancement (BPE)
can be performed based on breast and FGT segmentation. In the presented system, a
3-class U-net is used for segmenting the breast MRI volume into FGT, fat in breast and
outside-breast regions. Our experiments showed a signicant improvement in perfor-
mance measured by the DSC scores compared to the previously developed breast seg-
mentation algorithms that are based on conventional methods65,77. The improvement
was visible for both dense and non-dense breasts. Consequently, volumetric density
estimations computed based on 3-class U-net segmentations showed signicantly higher
correlation to the volume density estimations obtained from manual reference segmen-
tations, compared to the density values obtained from the conventional segmentation
methods. One weakness of the deep learning based method used in this study is that
there was no constraint on the shape of the resulting segmentation. Therefore obtain-
ing breast segmentations with plausible shapes is not guaranteed. This is an important
problem in deep learning based segmentation methods that requires further research.
In Chapter 4, we applied the segmentation method that was developed in Chapter
3 on a large dataset for a retrospective analysis of breast cancer risk and false positive
ndings in a population with increased risk of breast cancer. We computed various
measures, such as FGT amount, BD and BPE. Although BPE was suggested as a risk
factor in previous studies101{103, we have not found any signicant relation between
breast cancer occurrence and BPE in this population. False positive ndings were
signicantly correlated with BPE. The advantage of the automated methods used in
this study was in its objectivity. However, we applied a simple thresholding method
where we used the same threshold values for all MRI studies to compute BPE, while
the amount of enhancement may vary based on several factors such as the amount of
contrast agent, patient weight or magnetic eld strength. Therefore further studies
are needed to investigate the relation between breast cancer risk and more robust and
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advanced features of BPE.
Chapter 5 presents a deep learning based lesion detection system for abbreviated
breast MRI protocols that have been suggested for screening. The system focuses on
exploiting all spatial information available in the subtraction volumes obtained from the
pre-contrast and the rst post-contrast T1w MRI volumes. This information includes
not only the 3D shapes around the lesion candidate points, but also the symmetry
information that arises from the dierences in the enhancement of each breast of the
same women. The system makes use of the breast segmentation method presented in
the previous Chapter 3. The remarkable increase in sensitivity compared to a previ-
ously published conventional method, especially for the prior-visible lesions, indicate
the potential benets of the use of deep learning based computer-aid systems.
High dimensional and multiparametric nature of the information in breast MRI
makes computer-aid potentially useful in decision making, specically for distinguish-
ing the detected benign lesions from the malignant ones. In Chapter 6 we revisited the
lesion classication problem for ultrafast DCE-MRI, this time with deep learning. Fur-
thermore, we extended the problem to include other adjunct information available in the
clinical use, such as patient information and the information obtained from other MRI
sequences (DWI and T2w imaging). To use deep learning for a direct spatiotemporal
analysis for the ultrafast DCE-MRI sequence, we initially reduced its dimensionality
from 4D to 3D using maximum intensity projection (MIP) through axial planes at
patch level. In this way, 3D spatiotemporal patches were generated, in which the third
dimension is time. These patches were used to train a CNN classier. A CNN with
the same architecture was also used for the patches obtained from T2w images. We
obtained ADC values based on a thresholding method. When all information was com-
bined using a random forests classier, the system produced slightly higher specicity
compared to the clinical diagnosis obtained in this dataset.
Discussion
While automated image analysis systems have a long history, the use of deep learning
techniques since 2012 has resulted in revolutionary changes in this eld. Deep learn-
ing not only provides superior performance compared to the traditional methods in
most image analysis tasks, but also replaces feature engineering with automated fea-
ture learning. Consequently it has become the method of choice for computer vision
and image analysis tasks and it is reasonable to expect that most of the traditional
image analysis methods will be considered in only certain circumstances, such as when
the feature extraction is easy or fast for the given problem. The work presented in this
thesis shows that it is feasible to apply deep learning techniques to breast MRI and to
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obtain high performance even when the training dataset is not very large.
Unprecedented success of deep learning in image recognition revived the optimism
in automating image interpretation tasks at the performance level of humans. Only
in the last few years have we seen applications in various domains that reach or even
surpass human performance at certain image recognition tasks135,160,170. Consequently,
there have been discussions about the feasibility of replacing human labor with deep
learning based articial intelligence (AI) in various elds including radiology. However,
in order to avoid far-fetched expectations, it is important to understand the limitations
of these AI systems. Machine learning systems, including deep learning, are specialized
in solving isolated tasks, while human intelligence is able to develop understanding of
various concepts and is able to combine vast amount of information from dierent levels
and domains for performing tasks. A simple yet good example of how this creates
a dierence was given in the famous blog post of Artem Khurshudov `Suddenly, a
leopard print sofa appears'171. When Khurshudov tested the most advanced image
recognition systems using a picture of a sofa that has leopard-skin pattern, all of the
tested systems classied it as a leopard. For humans this is an easy classication
problem, because we combine our knowledge from various aspects, such as the shape
of a sofa, how it is used and the information from cultural context that dierent skin
patterns can be used for various objects for esthetic purposes. The only way a deep
learning system can deal with such anomalies is to have similar examples in the training
set, which is not a scalable solution since there will be countless examples that introduce
dierent kinds of anomalies. In other words, as soon as we increase the scope of the
task beyond recognizing standard objects towards dealing with countless of scenarios
that can happen in real life, the problem space becomes too large and complex to be
managed simply by introducing examples in the training set, and, starts to require a
higher level of intelligence. A similar example was given by a radiologist Phil Shaer,
where he explained how current AI fails to see the story in an image, while \radiologists
synthesize the objects in a scan into a coherent, meaningful interpretation: the patient's
story"172. Even after interpretation of the patient's story based on imaging and various
other information about a patient, radiologists need to make decisions for the next steps,
such as whether additional imaging or a biopsy is needed. In short, reading radiological
images is not always as simple as yes/no classication or detecting predened objects
in images, but also involves in-depth interpretation and complex decision making based
on the images and various other information about the patient. Therefore, I do not
expect deep learning to completely take over the task of radiological image reading, but
rather I expect it to be a base for powerful tools used by radiologists for automating
well-dened and time consuming tasks.
There are many labor intensive tasks in radiology, for which automation may bring
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Figure 6.6: Deep learning system classies the picture of a panda as gibbon after a noise was added
to the image.
about enormous eciency gains. For example, high number of images are produced in
screening programs, which creates a signicant amount of image reading work. Such
repetitive tasks can be performed by deep learning based systems. We have already seen
deep learning applications that reach human-level performance for some of the reading
tasks such as cancer detection in mammography images173 and pneumonia detection
in chest x-ray images174. There are also image-based quantication tasks that require
tedious work, which can be done by deep learning based systems. As an example,
Ghafoorian et al. developed a deep learning based system that approaches human level
performance in segmenting and quantifying white-matter hyperintensities brain MRIs,
which is a time consuming clinical task175. Similarly, in Chapter 3 of this thesis, we
reported a high performance for breast density computation with a deep learning based
breast and FGT segmentation, which requires tedious work for humans when done
manually.
The deep learning based lesion detection system proposed for breast MRI in Chapter
5 outperformed a traditional system and it can be used in assisting radiologists to
increase detection sensitivity. However, the performance of this system was still not
at a desired level to be used as a standalone reader. The CNN used in this study was
not deep, which was a decision based on the limited size of the dataset. Increased
amount of training data will make it possible to train deeper architectures, since deeper
networks have more parameters that rely on data for being optimized. Therefore, future
work should focus on building large databases of breast MRI and train deeper CNN
architectures to approach human level performance in cancer detection.
Another diculty for reaching human level performance in reading of various imag-
ing modalities including breast MRI is related to the limited generalizability capabilities
of deep learning. The previously given two examples, mammography and chest x-rays
are highly standardized imaging modalities, while there is a large variability in the
images obtained from dierent breast MRI units in dierent clinical centers due to
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the various image acquisition parameters, dierent magnetic elds strengths, contrast
agents and various other aspects of MRI acquisition units. Such variations make it
challenging for deep learning algorithms to generalize suciently for a general use,
since even slight changes in image properties such as resolution, noise patterns or con-
trast properties might make a deep learning system fail when similar properties are not
present in the training data, while human interpretation is substantially robust against
such variations. `Adversarial examples' are commonly used to demonstrate this limita-
tion of deep learning, as given in the example in Fig. 6.6, where the classier starts to
confuse a panda with a gibbon when a very small noise was inserted in the image176.
While being vulnerable, deep learning methods still possess an advantage compared to
the traditional methods as it is usually sucient to include the variety in the training
set without a requirement of re-designing features for each variation. This was shown
in Chapter 3, where we used 5 dierent MRI acquisition protocols in the training set
to develop a single solution for breast and FGT segmentation. The diculty arises
when data from other types of acquisition is not available. For such cases, a simple
yet not guaranteed method for improving generalizability of a deep learning system is
applying as many realistic augmentations as possible on the training data. In some
other situations, example images from a new type of acquisition maybe available, but
without labels. Recent advances in generative adversarial networks (GANs)177, which
is an unsupervised deep learning technique, has lead to promising approaches that can
be used for such situations. Several dierent ways of using GANs for such problems
have been suggested, such as transferring knowledge learned in one domain to another
domain178{180, or transferring the style of an unlabeled dataset to another style for
which labeled training data is available181,182. However, as shown with the `adversarial
examples'176,183,184, even for the most advanced deep learning image recognition systems
it is possible to nd noise patterns that can cause failure in image classication. There-
fore this is not a trivial problem and standardization of acquisition protocols has a key
importance for generalizability of deep learning based medical image analysis systems.
The current standard imaging modality for screening is mammography. However,
compared to breast MRI, mammography has a lower sensitivity as some of the lesions
are mammographically occult and some lesions can be obscured by the broglandular
tissue in dense breasts due to overlapping of tissue in 2D imaging. The problem of tissue
overlap can be partly overcome by the use of the newer pseudo-3D imaging modality
digital breast tomosynthesis (DBT). However, both modalities tend to be better at
detection of slow-growing and less aggressive tumors9 since detectability on these X-
ray based images relies on slow changing properties such as calcication or architectural
distortion. Breast MRI has a higher sensitivity than mammography for any type of
breast cancer, while tumor visibility in breast MRI increases with the aggressiveness
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of the cancer since it relies on the angiogenetic processes that maintain the growth
of the cancer. The high sensitivity of breast MRI to detect cancers implies that it
has a clear benet in screening. Particularly its propensity to preferentially detect
aggressive cancers implies that it may improve the breast cancer related mortality gain
of screening. Therefore, more widespread use of breast MRI is desirable especially for
screening. Although the high cost of breast MRI is a limiting factor, novel ultrafast
DCE-MRI sequences and abbreviated breast MRI protocols allow reducing the cost by
shortening the scan duration. Automated image analysis and deep learning may also
play an important role here by making it feasible to read increased number of breast MRI
scans, since reading these high dimensional images is time consuming for radiologists.
Automated non-invasive assessment of cancer aggressiveness and metastatic potential is
also an important future research direction in this regard, since detecting more lesions
might lead to an increase in overdiagnosis.
Another important aspect in breast cancer screening is risk-based personalization.
Simpler methods of imaging with less frequency of screening intervals can be used for
women with lower breast cancer risk, while women with increased risk can be screened
with more advanced imaging modalities with higher frequency. Currently breast can-
cer risk assessment is based on risk factors such as family history, the presence of a
BRCA gene mutation, age, breast density, etc. Risk assessment can be improved by
using imaging based biomarkers. Deep learning can play an important role in improving
the risk assessment by learning risk related features in the images based on examples
in large imaging databases. Li et al.185 and Wanders et al.186 applied deep learning
to mammography images to learn risk-related features and both obtained promising
results. Changes in breast density over years can be another important biomarker of
breast cancer risk187, for which automated quantication methods, such as the one pro-
posed in Chapter 3, can be used on breast MRI to obtain precise density measurements.
BPE was suggested as another imaging based biomarker of breast cancer risk. The work
presented in Chapter 4 did not reveal a relation between BPE and breast cancer risk.
However, we used a simple thresholding method to determine BPE, while a deep learn-
ing based analysis using in a large breast MRI database might reveal relations between
breast cancer risk and more complex features of the patterns in BPE which are as yet
unknown.
Potential contribution of the novel ultrafast breast MRI protocols in histopatho-
logical diagnosis may be another promising research topic. Automated image analysis
methods usually focus on detecting cancer in images or classifying benign and malig-
nant lesions. Similarly, in Chapter 2 and Chapter 6, we used semi-quantitative fea-
tures and automated feature learning for benign and malignant classication. However,
the nal diagnosis of cancer depends on more information than malignancy, such as
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histopatholgical grade or molecular subtypes of the tumors. In theory, it is possible
to measure some of the cancer-related physiological tissue properties in lesions such
as ve (volume of extracellular, extravascular space) or K
trans (capillary permeability)
using DCE-MRI data, based on pharmacokinetical models such as Tofts188 or Brix189.
As the heterogeneity in tumors brings about certain challenges such as in determining
the place to take the biopsy from, model based automated analysis can contribute in
the histopathological diagnosis processes by providing detailed information about the
physiological properties and heterogeneity of the tissue. Until now, such approaches
have not resulted in a consistent success in the breast MRI protocols used in clinical
routine, mainly due to the limited spatial and temporal resolution. Improvements in
spatiotemporal resolution introduced by the novel ultrafast sequences might make it
feasible to make use of these methods in clinical routine.
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MRI is een onmisbare beeldvormende techniek bij borstonderzoek, vanwege zijn hoge
sensitiviteit voor het detecteren van borstkanker. Hoewel er ook goedaardige laesies
voorkomen in borst-MRI, is het mogelijk om ze te onderscheiden van kwaadaardige
laesies door ze te interpreteren op basis van hun morfologie, aankleuring en andere
aanvullende informatie, zoals hun diusie-eigenschappen afgebeeld met DWI en hun
presentatie op T2w-beelden. Ondanks zijn hoge gevoeligheid wordt borst-MRI om ver-
schillende redenen niet gebruikt voor algemene screening op borstkanker, zoals de hoge
kosten, de noodzaak om een contrastmiddel te gebruiken, de duur van het onderzoek, en
het tijdrovende leesproces van de hoogdimensionale en multiparametrische informatie
die met MRI gepaard gaan. Nieuwe DCE-MRI-sequenties en borst-MRI-protocollen
pakken het probleem met betrekking tot de acquisitieduur aan met verschillende strate-
gien, zoals het gebruik van slimme manieren om de k-ruimte te bemonsteren in ultra-
fast DCE-MRI-sequenties of het acquisitieprotocol te beperken tot enkel de vastlegging
van de morfologie. De leesecintie van borst-MRI kan worden verbeterd met behulp
van computerprogramma's die afbeeldingen automatisch analyseren door gebruik te
maken van machine learning en computer vision-methoden. Hoewel er verschillende
eerdere studies zijn geweest naar computergestuurde detectie en diagnose van laesies
in borst MRI18{28, richt dit proefschrift zich op nieuwe borst-MRI-protocollen die van
essentieel belang kunnen zijn bij een bredere inzet van deze beeldvormingsmodaliteit.
Bovendien waren eerder ontwikkelde geautomatiseerde analysesystemen voor borst-MRI
gebaseerd op traditionele machine learning en computer vision-methoden, terwijl deze
onderzoeksvelden de laatste jaren een snelle en revolutionaire transformatie hebben
ondergaan door de introductie van algoritmen die 'deep learning' worden genoemd.
Anders dan de conventionele methoden waarvoor handmatig functies moeten worden
ontworpen die die belangrijkste kenmerken extraheren, leren deep learning algoritmen
de specieke kenmerken van het probleem automatisch op basis van trainingsdata. Het
blijkt dat deze aanpak de conventionele methoden kan overtreen, vooral als er veel
trainingsdata beschikbaar is. In de afgelopen jaren heeft er daarom ook een transitie
plaatsgevonden in de computervision- en machine-learning wereld van conventionele
methoden naar op deep learning gebaseerde methoden. Deze transitie is ook te zien in
dit proefschrift, aangezien we beginnen met conventionele methoden en vervolgen met
deep learning methoden waarbij we de laatste met de eerste vergelijken.
Hoofdstuk 2 van dit proefschrift beschrijft een computergestuurd diagnosesysteem
(CAD) voor ultrafast borst DCE-MRI dat kwaadaardige en goedaardige laesies classi-
ceert met behulp van traditionele beeldanalyse en machine-learning methoden. Het
CAD-systeem extraheert aankleurings- en morfologische kenmerken voor elke laesie op
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basis van een semi-automatische segmentatie. Aankleuringskenmerken worden automa-
tisch genormaliseerd op basis van de aankleuringstijd van de aorta. In onze exper-
imenten deed dit systeem het aanzienlijk beter dan een eerder ontwikkeld systeem,
vooral voor de evaluatie van de aankleuring van de laesies. We zagen echter ook dat
de evaluatie van de morfologie achter bleef voor dit systeem, ondanks de verbeteringen
in de segmentatiemethode die de randen van de laesie denieert. Het evalueren van
morfologische informatie is moeilijk met conventionele methoden, aangezien dit een
zorgvuldig ontwerp vereist van functies die de kenmerken extraheren die relevant zijn
voor de classicatie van laesies. Daarnaast worden aankleuringskenmerken op voxel-
niveau berekend, zonder rekening te houden met de informatie in naburige voxels. Dit
classicatieprobleem wordt later besproken in hoofdstuk 6, waarin deep learning wordt
gebruikt voor een gecombineerde spatiotemporele analyse waarvoor geen handmatig
ontwerp van functies vereist is.
We zijn begonnen met het verkennen van het gebruik van deep learning methoden
in geautomatiseerde analyse van borst-MRI in hoofdstuk 3. In dit hoofdstuk hebben
we een fully convolutional neural network onderzocht die bekend staat als `U-Net` voor
het segmenteren van borst- en klierweefsel (FGT) in T1w MRI volumes. Borstseg-
mentatie kent een belangrijke toepassing in geautomatiseerde analyse van borst-MRI,
aangezien de meeste geautomatiseerde laesie-detectiealgoritmen het als een eerste stap
vereisen om het gebied te deniren om naar laesies te zoeken. Daarnaast kunnen metin-
gen zoals BD of BPE worden uitgevoerd op basis van borst- en FGT-segmentatie. In
het gepresenteerde systeem wordt een U-net gebruikt voor het segmenteren van het
borst-MRI-volume in 3 klasses, te weten FGT, vet in de borst, en achtergrond. Onze
experimenten lieten een aanzienlijke verbetering zien, gemeten met DSC-scores, ten
opzichte van de eerder ontwikkelde borstsegmentatiealgoritmen die gebaseerd zijn op
conventionele methoden65,77. De verbetering was zichtbaar voor zowel borsten met
veel als borsten met weinig klierweefsel. Hierdoor was de correlatie met volumetrische
densiteitsschattingen verkregen uit handmatige segmentaties ter referentie, signicant
hoger voor de 3-klasse U-net-segmentaties dan voor de conventionele segmentatiemeth-
oden. Een zwak punt van de op deep learning gebaseerde methode die in deze studie
wordt gebruikt, is dat er geen beperking was voor de vorm van de verkregen segmentatie.
Daarom is het niet gegarandeerd dat er borstsegmentaties worden verkregen die plau-
sibele vormen hebben. Dit is een belangrijk probleem bij op deep learning gebaseerde
segmentatiemethoden waarvoor verder onderzoek nodig is.
In hoofdstuk 4 hebben we de segmentatiemethode die in hoofdstuk 3 werd on-
twikkeld toegepast op een grote dataset voor een retrospectieve analyse van het risico
op borstkanker en fout positieve bevindingen bij een populatie met een verhoogd risico
op borstkanker. We hebben verschillende parameters berekend, zoals de hoeveelheid
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klierweefsel, borstdichtheid (BD) en achtergrondaankleuring (BPE). Hoewel BPE werd
geopperd als een risicofactor in eerdere studies101{103, hebben we in deze populatie geen
signicante relatie gevonden tussen het voorkomen van borstkanker en BPE. Fout posi-
tieve bevindingen waren signicant gecorreleerd met BPE. Het voordeel van de geau-
tomatiseerde methoden die in dit onderzoek werden gebruikt, was de objectiviteit. We
hebben echter een eenvoudige thresholdmethode toegepast waarbij we voor alle MRI-
onderzoeken dezelfde drempelwaarden hebben gebruikt om BPE te berekenen, terwijl
de hoeveelheid aankleuring kan variren op basis van verschillende factoren, zoals de
hoeveelheid contrastmiddel, het gewicht van de patint of de magnetische veldsterkte.
Daarom is meer onderzoek nodig om de relatie tussen het risico op borstkanker en meer
robuuste en geavanceerde kenmerken van BPE te onderzoeken.
Hoofdstuk 5 beschrijft een op deep learning gebaseerd tumor detectiesysteem voor
verkorte borst-MRI-protocollen die zijn voorgesteld als screening-methode. Het sys-
teem is gericht op het benutten van alle beschikbare spatile informatie in de subtrac-
tievolumes, die verkregen zijn uit de pre-contrast en de eerste post-contrast T1w MRI-
volumes. Deze informatie omvat niet alleen de 3D-vormen rond de kandidaat-punten
van de laesie, maar ook de symmetrie-informatie die voortkomt uit de verschillen in
de aankleuring van elke borst van dezelfde vrouw. Het systeem maakt gebruik van de
borstsegmentatiemethode die in het vorige hoofdstuk 3 werd gepresenteerd. De op-
merkelijke toename van de sensitiviteit ten opzichte van een eerder gepubliceerde con-
ventionele methode, vooral voor de prior-visible laesies, toont de potentile voordelen
van het gebruik van op deep learning gebaseerde computergestuurde diagnosesystemen.
De hoogdimensionale en multiparametrische aard van de informatie in borst-MRI
maakt computergestuurde diagnosesystemen mogelijk nuttig bij het nemen van beslissin-
gen, in het bijzonder voor het het maken van een onderscheid tussen gedetecteerde
goedaardige laesies en kwaadaardige laesies. In hoofdstuk 6 hebben we het laesie clas-
sicatie probleem voor ultrafast DCE-MRI opnieuw bekeken, dit keer met deep learn-
ing. Verder hebben we het probleem uitgebreid met andere aanvullende informatie die
beschikbaar is in het klinisch gebruik, zoals patintinformatie en de informatie verkre-
gen uit andere MRI-sequenties (DWI- en T2w-beeldvorming). Om deep learning te ge-
bruiken voor een directe spatiotemporele analyse van de ultrafast DCE-MRI-sequentie,
hebben we aanvankelijk de dimensionaliteit gereduceerd van 4D tot 3D door middel
van maximale intensiteitsprojectie (MIP) door axiale vlakken op patch-niveau. Op
deze manier werden 3D spatiotemporele patches gegenereerd, waarbij de derde dimen-
sie de tijd is. Deze patches werden gebruikt om een CNN-classier te trainen. Een
CNN met dezelfde architectuur werd ook gebruikt voor de patches verkregen uit T2w-
afbeeldingen. ADC-waarden werden verkregen op basis van een thresholdmethode.
Wanneer alle informatie werd gecombineerd middels een random forests-classier, pro-
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duceerde het systeem een iets hogere speciciteit vergeleken met de klinische diagnose
die in deze dataset werd verkregen.
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